Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ACHC HCA UHS CYH CNC THC MOH PRVA AMWL HQY

| Held by: VTI IWM VB VBK VXF DFAS SCHA DFSV VTWO IWO

Index	RUT	P/E	257.39	EPS (ttm)	0.03	Insider Own	58.81%	Shs Outstand	388.32M	Perf Week	-7.41%
Market Cap	2.51B	Forward P/E	45.03	EPS next Y	0.14	Insider Trans	-9.95%	Shs Float	160.56M	Perf Month	-7.41%
Enterprise Value	2.73B	PEG	0.29	EPS next Q	0.01	Inst Own	42.71%	Short Float	6.43%	Perf Quarter	-0.70%
Income	9.66M	P/S	1.76	EPS this Y	265.51%	Inst Trans	3.00%	Short Ratio	4.39	Perf Half Y	24.46%
Sales	1.42B	P/B	1.64	EPS next Y	95.46%	ROA	0.43%	Short Interest	10.32M	Perf YTD	-8.60%
Book/sh	3.92	P/C	10.09	EPS next 5Y	155.28%	ROE	0.65%	52W High	8.09 -20.46%	Perf Year	-6.06%
Cash/sh	0.64	P/FCF	22.80	EPS past 3/5Y	- -	ROIC	0.50%	52W Low	3.74 72.05%	Perf 3Y	12.89%
Dividend Est.	-	EV/EBITDA	33.90	Sales past 3/5Y	18.33% 30.44%	Gross Margin	28.53%	Volatility	3.86% 4.20%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.92	EPS Y/Y TTM	116.56%	Oper. Margin	1.82%	ATR (14)	0.30	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.65	Sales Y/Y TTM	13.85%	Profit Margin	0.68%	RSI (14)	34.22	Recom	1.30
Dividend Gr. 3/5Y	- -	Current Ratio	1.65	EPS Q/Q	262.37%	SMA20	-8.49%	Beta	1.12	Target Price	9.83
Payout	0.00%	Debt/Eq	0.31	Sales Q/Q	17.43%	SMA50	-9.33%	Rel Volume	0.35	Prev Close	6.64
Employees	10961	LT Debt/Eq	0.27	Earnings	Feb 25 BMO	SMA200	9.79%	Avg Volume	2.35M	Price	6.43
IPO	Jun 10, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	1211.11% 1.00%	Trades		Volume	711,418	Change	-3.09%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Initiated	Barclays	Overweight	$8
Nov-13-25	Initiated	BMO Capital Markets	Outperform	$8
Jul-25-25	Initiated	BTIG Research	Buy	$8
May-27-25	Upgrade	UBS	Neutral → Buy	$8.50
Apr-08-25	Initiated	KeyBanc Capital Markets	Overweight	$9
Apr-03-25	Initiated	Canaccord Genuity	Buy	$8
Dec-16-24	Upgrade	Goldman	Neutral → Buy	$10
Jan-03-24	Initiated	Barclays	Underweight	$7
May-15-23	Downgrade	TD Cowen	Outperform → Market Perform	$8 → $9
Jan-06-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$8
Nov-07-22	Resumed	Jefferies	Buy	$7.25
Mar-17-22	Downgrade	UBS	Buy → Neutral	$19 → $10
Nov-09-21	Downgrade	JP Morgan	Overweight → Neutral	$24 → $12
Sep-10-21	Initiated	Cowen	Outperform	$18
Aug-16-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$36 → $16
Jul-06-21	Initiated	William Blair	Outperform
Jul-06-21	Initiated	Morgan Stanley	Overweight	$36
Jul-06-21	Initiated	JP Morgan	Overweight	$36
Jul-06-21	Initiated	Jefferies	Buy	$36
Jul-06-21	Initiated	Goldman	Neutral	$25

Show Previous Ratings

Feb-28-26 02:14AM	Canaccord Lifts PT on LifeStance Health Group (LFST) to $10 From $9, Here's Why (Insider Monkey)
Feb-25-26 04:48PM	LifeStance Health Group Announces Launch of Secondary Public Offering (GlobeNewswire) -6.07%
04:02PM	LifeStance Health Group Inc (LFST) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
03:29PM	LifeStance Health Group Q4 Earnings Call Highlights (MarketBeat)
12:34PM	LifeStance Health Group, Inc. Q4 2025 Earnings Call Summary (Moby)
12:15PM	Loading…
12:15PM	LifeStance Health Group (LFST) Q4 Earnings and Revenues Top Estimates (Zacks)
06:45AM	LifeStance Health Group (NASDAQ:LFST) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Jumps 12.7% (StockStory)
06:22AM	LifeStance Health: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	LifeStance Reports Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Feb-24-26 07:24AM	LifeStance Health Group Inc (LFST) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-09-26 04:10PM	LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026 (GlobeNewswire)
Feb-02-26 05:20PM	DaVita HealthCare (DVA) Q4 Earnings and Revenues Surpass Estimates (Zacks)
Jan-22-26 02:14PM	Analysts Turn More Bullish on LifeStance Health Group (LFST) After Dual Price Target Hikes (Insider Monkey)
Dec-22-25 06:05AM	2026 Medical Utilization Forecasts Support BTIG's Bullish View on LifeStance (LFST) (Insider Monkey)
Dec-11-25 10:33PM	Spotting Winners: LifeStance Health Group (NASDAQ:LFST) And Outpatient & Specialty Care Stocks In Q3 (StockStory)
09:55AM	Loading…
Nov-28-25 09:55AM	Wall Street Analysts Think LifeStance Health (LFST) Could Surge 30.49%: Read This Before Placing a Bet (Zacks)
Nov-20-25 11:02PM	3 Reasons to Sell LFST and 1 Stock to Buy Instead (StockStory)
Nov-13-25 12:37AM	The 5 Most Interesting Analyst Questions From LifeStance Health Group's Q3 Earnings Call (StockStory)
Nov-12-25 09:55AM	Wall Street Analysts See a 33.38% Upside in LifeStance Health (LFST): Can the Stock Really Move This High? (Zacks)
Nov-08-25 05:11AM	LifeStance (LFST) Soars 30% on Q3 Earnings Blowout (Insider Monkey)
Nov-07-25 12:32AM	LFST Q3 Deep Dive: Productivity Initiatives and Tech Investment Drive Behavioral Health Growth (StockStory)
Nov-06-25 07:15AM	LifeStance Health Group (LFST) Reports Break-Even Earnings for Q3 (Zacks) +29.94%
06:12AM	LifeStance Health Group's (NASDAQ:LFST) Q3 Sales Top Estimates (StockStory)
06:00AM	LifeStance Reports Third Quarter 2025 Results (GlobeNewswire)
Nov-05-25 09:00AM	Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season (PR Newswire)
07:34AM	What To Expect From LifeStance Health Group Inc (LFST) Q3 2025 Earnings (GuruFocus.com)
Nov-04-25 10:22PM	LifeStance Health Group (LFST) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-28-25 04:10PM	LifeStance to Present at the UBS Global Healthcare Conference (GlobeNewswire)
09:00AM	Calm Health Partners with LifeStance Health to Help Users Access High-Quality Mental Health Care (PR Newswire)
Oct-16-25 04:10PM	LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025 (GlobeNewswire)
03:50PM	Loading…
Oct-10-25 03:50PM	LifeStance Health Group, Azenta, PacBio, GE HealthCare, and ICU Medical Shares Are Falling, What You Need To Know (StockStory) -5.78%
Oct-08-25 12:00PM	All You Need to Know About LifeStance Health (LFST) Rating Upgrade to Strong Buy (Zacks)
Sep-26-25 10:21AM	Just How Healthy Is the Business of Mental Health? (Barrons.com)
10:09AM	The Stock Market Is Up, but the Dollar Is Down. What It Means for You. (Barrons.com)
Sep-15-25 11:31PM	Winners And Losers Of Q2: LifeStance Health Group (NASDAQ:LFST) Vs The Rest Of The Outpatient & Specialty Care Stocks (StockStory)
Sep-12-25 12:03AM	3 Reasons LFST is Risky and 1 Stock to Buy Instead (StockStory)
Sep-10-25 03:11PM	Why LifeStance Health Group (LFST) Shares Are Getting Obliterated Today (StockStory) -5.74%
Aug-26-25 04:10PM	LifeStance to Present at the 23rd Annual Morgan Stanley Healthcare Conference (GlobeNewswire)
Aug-22-25 09:00AM	Sarah Personette Appointed to LifeStance Board of Directors (PR Newswire)
Aug-17-25 06:20PM	LifeStance Health (LFST) Accelerates Growth with AI-Enabled Operations and Clinician Expansion (Insider Monkey)
Aug-15-25 11:02AM	LifeStance (LFST) Extends Rally to 5th Day on Strong Investor Confidence (Insider Monkey)
Aug-14-25 01:46PM	LifeStance (LFST) Extends 4-Day Run on Strong Earnings (Insider Monkey) +7.93%
01:33AM	The 5 Most Interesting Analyst Questions From LifeStance Health Group's Q2 Earnings Call (StockStory)
Aug-12-25 03:23AM	LFST Q2 Deep Dive: Productivity Initiatives and Technology Investments Drive Margin Expansion (StockStory)
Aug-11-25 07:45AM	UBS Raised the Firm's PT on LifeStance Health Group (LFST), Kept a Buy Rating (Insider Monkey)
Aug-08-25 02:21PM	Why LifeStance Health Group (LFST) Stock Is Up Today (StockStory) +13.21%
Aug-07-25 01:45PM	LifeStance Health Group's (NASDAQ:LFST) Q2 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Slightly Misses Expectations (StockStory)
07:15AM	LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:11AM	LifeStance Health: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	LifeStance Reports Second Quarter 2025 Results (GlobeNewswire)
Aug-05-25 11:08PM	LifeStance Health Group (LFST) Reports Earnings Tomorrow: What To Expect (StockStory)
Aug-01-25 06:47AM	Lifestance Health Group (LFST) Rated as a Buy at BTIG amid Commercially Insured Patients Boost (Insider Monkey)
12:38AM	3 Small-Cap Stocks We Find Risky (StockStory)
Jul-23-25 11:25AM	LifeStance Health (LFST) Appoints Vaughn Paunovich as Chief Technology Officer (Insider Monkey)
Jul-22-25 09:00AM	'Stressflation' is Here: 83% of Americans Say Today's Economic Climate is Taking a Toll on Their Mental Health (PR Newswire)
Jul-17-25 04:10PM	LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025 (GlobeNewswire)
Jul-14-25 12:06AM	3 Reasons to Avoid LFST and 1 Stock to Buy Instead (StockStory)
Jul-11-25 03:30PM	Why LifeStance Health Group (LFST) Stock Is Trading Lower Today (StockStory)
07:17AM	Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks)
Jul-07-25 09:10AM	Morgan Stanley Maintains a Buy Rating on LifeStance Health (LFST), Keeps the PT at $10 (Insider Monkey)
Jul-02-25 01:35AM	5 Revealing Analyst Questions From LifeStance Health Group's Q1 Earnings Call (StockStory)
Jun-27-25 12:00PM	LifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Jun-16-25 09:35AM	After Plunging 9.9% in 4 Weeks, Here's Why the Trend Might Reverse for LifeStance Health (LFST) (Zacks)
Jun-10-25 12:31PM	LFST Q1 Earnings Call: Outpatient Behavioral Health Sees Stable Growth, Margin Improvement, and Shifts in Clinician Incentives (StockStory)
Jun-05-25 09:55AM	Wall Street Analysts Think LifeStance Health (LFST) Could Surge 45.04%: Read This Before Placing a Bet (Zacks)
May-28-25 04:10PM	LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference (GlobeNewswire)
May-27-25 11:35AM	Southwest bag fees, LifeStance upgrade, AutoZone earnings (Yahoo Finance Video) +10.38%
May-25-25 11:31PM	Q1 Earnings Highlights: LifeStance Health Group (NASDAQ:LFST) Vs The Rest Of The Outpatient & Specialty Care Stocks (StockStory)
May-14-25 09:00AM	LifeStance Names Vaughn Paunovich as Chief Technology Officer (PR Newswire)
May-08-25 12:00PM	LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why (Zacks) +5.44%
09:35AM	Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround (Zacks)
03:14AM	LifeStance Health Group Inc (LFST) Q1 2025 Earnings Call Highlights: A Promising Start with ... (GuruFocus.com)
May-07-25 07:10AM	LifeStance Health Group (LFST) Reports Break-Even Earnings for Q1 (Zacks) -15.88%
06:00AM	LifeStance Reports First Quarter 2025 Results (GlobeNewswire)
May-06-25 04:05PM	Lifeist Announces Leadership Changes to Advance Strategy of Streamlining Operations and Improving Organizational Efficiency (GlobeNewswire)
May-05-25 09:55AM	Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 28.68%: Here's is How to Trade (Zacks)
Apr-30-25 10:01AM	LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-29-25 09:05AM	3 of Wall Street's Favorite Stocks with Questionable Fundamentals (StockStory)
Apr-22-25 06:12AM	LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion (Seeking Alpha)
Apr-21-25 04:10PM	LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025 (GlobeNewswire) -8.06%
Apr-18-25 09:02AM	3 Healthcare Stocks with Questionable Fundamentals (StockStory)
Apr-16-25 05:11AM	3 Reasons LFST is Risky and 1 Stock to Buy Instead (StockStory)
Apr-15-25 09:00AM	LifeStance Survey Finds Nearly One-Third of Americans Use Social Media Content to Self-Diagnose Mental Health Conditions (PR Newswire)
Apr-10-25 11:38AM	Addus HomeCare (ADUS) Surges 4.9%: Is This an Indication of Further Gains? (Zacks)
11:37AM	LifeStance Health (LFST) Surges 5.8%: Is This an Indication of Further Gains? (Zacks)
09:55AM	Wall Street Analysts See a 26.63% Upside in LifeStance Health (LFST): Can the Stock Really Move This High? (Zacks)
Mar-21-25 09:55AM	LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Mar-13-25 05:01AM	Outpatient & Specialty Care Stocks Q4 Results: Benchmarking U.S. Physical Therapy (NYSE:USPH) (StockStory)
Feb-28-25 02:17AM	LifeStance Health Group Inc (LFST) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
01:49AM	Q4 2024 Lifestance Health Group Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-27-25 11:13AM	Dave Bourdon to join LifeStance Health as new CEO (Hospital Management)
07:35AM	LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:20AM	LifeStance Health Group (NASDAQ:LFST) Beats Expectations in Strong Q4, Stock Soars (StockStory)
06:02AM	LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman (PR Newswire)
06:00AM	LifeStance Reports Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Feb-26-25 08:02AM	LifeStance Health Group (LFST) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
07:26AM	LifeStance Health Group Inc (LFST) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-20-25 10:01AM	LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Feb-06-25 04:10PM	LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025 (GlobeNewswire)
Jan-17-25 12:00PM	LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know (Zacks)

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TPG GP A, LLC	10% Owner	Mar 02 '26	Sale	7.01	20,685,061	145,002,278	140,026,557	Mar 04 04:32 PM
BLACK DARREN M.	Director	Mar 02 '26	Sale	7.01	4,314,939	30,247,722	29,209,776	Mar 04 04:05 PM
Bessler Robert	Director	Dec 19 '25	Sale	7.04	119,942	844,392	1,318,983	Dec 23 07:53 PM
Bessler Robert	Director	Dec 22 '25	Sale	7.04	1,701	11,975	1,318,133	Dec 23 07:53 PM
Bessler Robert	Director	Dec 22 '25	Proposed Sale	7.04	1,701	11,975		Dec 22 04:30 PM
Bessler Robert	Director	Dec 18 '25	Sale	7.00	6,442	45,094	1,378,954	Dec 19 04:55 PM
Varanakis Ann	Chief People Officer	Dec 17 '25	Sale	6.90	50,000	345,000	315,610	Dec 19 04:49 PM
Bessler Robert	Director	Dec 19 '25	Proposed Sale	7.04	119,942	844,056		Dec 19 04:07 PM
Bessler Robert	Director	Dec 18 '25	Proposed Sale	7.00	6,442	45,113		Dec 18 04:02 PM
Varanakis Ann	Officer	Dec 17 '25	Proposed Sale	6.90	50,000	344,843		Dec 17 04:13 PM
Bessler Robert	Director	Dec 12 '25	Sale	7.01	79,630	558,206	1,382,175	Dec 16 07:49 PM
Bessler Robert	Director	Dec 15 '25	Sale	7.00	12,371	86,597	1,375,989	Dec 16 07:49 PM
Bessler Robert	Director	Dec 15 '25	Proposed Sale	7.00	12,371	86,622		Dec 15 04:12 PM
Bessler Robert	Director	Dec 12 '25	Proposed Sale	7.01	79,630	558,222		Dec 12 04:17 PM
Miller Lisa K	See Remarks	Nov 21 '25	Sale	6.43	57,240	368,053	261,292	Nov 25 04:25 PM
Miller Lisa K	Officer	Nov 21 '25	Proposed Sale	6.43	57,240	368,143		Nov 21 04:38 PM
Silversmith Partners I GP, LLC	Member of 10% Group	Aug 18 '25	Sale	5.07	3,592,357	18,213,250	14,324,197	Aug 20 04:49 PM
BLACK DARREN M.	Director	Aug 18 '25	Sale	5.07	8,407,643	42,626,750	33,524,715	Aug 20 04:47 PM
SUMMIT PARTNERS L P	10% Owner	Aug 18 '25	Sale	5.07	8,407,643	42,626,750	33,524,715	Aug 20 04:34 PM
Silversmith Capital Partners I	Shareholder	Aug 18 '25	Proposed Sale	5.41	894,098	4,837,070		Aug 18 08:42 PM
Silversmith Capital Partners I	Shareholder	Aug 18 '25	Proposed Sale	5.41	2,471,741	13,372,119		Aug 18 08:41 PM
Silversmith Capital Partners I	Shareholder	Aug 18 '25	Proposed Sale	5.41	226,518	1,225,462		Aug 18 08:39 PM
SUMMIT PARTNERS GROWTH EQUITY	Owner	Aug 18 '25	Proposed Sale	5.41	3,214,648	17,391,246		Aug 18 08:37 PM
SUMMIT PARTNERS GROWTH EQUITY	Owner	Aug 18 '25	Proposed Sale	5.41	5,148,494	27,853,353		Aug 18 08:36 PM
SUMMIT PARTNERS ENTREPRENEUR A	Owner	Aug 18 '25	Proposed Sale	5.41	4,804	25,990		Aug 18 08:34 PM
SUMMIT INVESTORS GE IX-VC IV,	Owner	Aug 18 '25	Proposed Sale	5.41	35,938	194,425		Aug 18 08:32 PM
SUMMIT INVESTORS GE IX/VC IV (	Owner	Aug 18 '25	Proposed Sale	5.41	3,759	20,336		Aug 18 08:30 PM
Burdick Kenneth A	Director	Aug 08 '25	Buy	4.36	47,670	207,751	3,416,571	Aug 12 04:30 PM
Burdick Kenneth A	Director	Aug 08 '25	Buy	4.30	46,511	199,997	46,511	Aug 12 04:30 PM
Burdick Kenneth A	Director	Aug 11 '25	Buy	4.53	20,000	90,545	3,436,571	Aug 12 04:30 PM
Ramtekkar Ujjwal	Chief Medical Officer	Jun 16 '25	Sale	5.17	9,519	49,213	103,916	Jun 18 04:00 PM
Ramtekkar Ujjwal	Officer	Jun 16 '25	Proposed Sale	5.17	9,519	49,213		Jun 16 04:09 PM
Ramtekkar Ujjwal	Chief Medical Officer	Jun 05 '25	Sale	5.94	16,000	95,040	113,435	Jun 09 05:00 PM
Ramtekkar Ujjwal	Officer	Jun 05 '25	Proposed Sale	5.94	16,000	94,961		Jun 05 04:45 PM
Bessler Robert	Director	Apr 09 '25	Sale	7.01	4,900	34,349	1,421,990	Apr 10 04:30 PM
Bessler Robert	Director	Apr 08 '25	Sale	7.00	14	98	1,424,440	Apr 10 04:30 PM
Bessler Robert	Director	Apr 09 '25	Proposed Sale	7.01	4,900	34,338		Apr 09 04:07 PM
Bessler Robert	Director	Apr 08 '25	Proposed Sale	7.00	14	98		Apr 08 04:15 PM
Miller Lisa K	See Remarks	Mar 17 '25	Sale	6.90	18,845	130,030	339,810	Mar 18 07:29 PM
Miller Lisa K	Officer	Mar 17 '25	Proposed Sale	6.90	18,845	129,993		Mar 17 04:05 PM

Open in Screener

SION

Sionna Therapeutics Inc

Mar 12 • 03:08PM ET

36.62

-1.76 -4.59 %

Healthcare • Biotechnology • USA • NASD

SION Sionna Therapeutics Inc daily Stock Chart

Held by: VTI XBI IWM VXF IBB IWO VTWO SCHA SBIO IWC

Index	RUT	P/E	-	EPS (ttm)	-1.70	Insider Own	44.35%	Shs Outstand	44.72M	Perf Week	5.95%
Market Cap	1.65B	Forward P/E	-	EPS next Y	-2.69	Insider Trans	-9.14%	Shs Float	25.04M	Perf Month	-3.68%
Enterprise Value	1.42B	PEG	-	EPS next Q	-0.52	Inst Own	59.74%	Short Float	13.38%	Perf Quarter	-11.96%
Income	-75.27M	P/S	-	EPS this Y	-23.69%	Inst Trans	6.55%	Short Ratio	10.99	Perf Half Y	56.01%
Sales	0.00M	P/B	5.34	EPS next Y	-15.89%	ROA	-29.31%	Short Interest	3.35M	Perf YTD	-10.99%
Book/sh	6.86	P/C	6.99	EPS next 5Y	-17.87%	ROE	-31.79%	52W High	45.00 -18.63%	Perf Year	114.01%
Cash/sh	5.24	P/FCF	-	EPS past 3/5Y	-22.66% -	ROIC	-23.95%	52W Low	7.26 404.71%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.38% 6.58%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-21.34%	Oper. Margin	-	ATR (14)	2.62	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	20.61	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	47.30	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	20.61	EPS Q/Q	-27.23%	SMA20	-0.15%	Beta	3.90	Target Price	49.11
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	-5.36%	Rel Volume	0.42	Prev Close	38.38
Employees	59	LT Debt/Eq	0.02	Earnings	Mar 02 BMO	SMA200	21.28%	Avg Volume	304.73K	Price	36.62
IPO	Feb 07, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	14.66% -	Trades		Volume	111,048	Change	-4.59%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-24-26	Initiated	Citizens	Mkt Outperform	$63
Dec-01-25	Downgrade	RBC Capital Mkts	Sector Perform → Underperform	$24
Nov-19-25	Initiated	BTIG Research	Buy	$50
Sep-03-25	Initiated	RBC Capital Mkts	Sector Perform	$22
Sep-03-25	Initiated	Raymond James	Strong Buy	$45
Mar-04-25	Initiated	TD Cowen	Buy
Mar-04-25	Initiated	Stifel	Buy	$32
Mar-04-25	Initiated	Guggenheim	Buy	$45

Mar-02-26 07:00AM	Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire) -7.17%
Feb-23-26 08:00AM	Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences (GlobeNewswire)
Feb-15-26 04:41AM	Sionna Therapeutics Maps Mid-2026 CF Catalysts, Highlights NBD1 Stabilizers at Guggenheim Summit (MarketBeat)
Feb-04-26 07:00AM	Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 (GlobeNewswire) -7.12%
Jan-05-26 07:00AM	Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
09:33AM	Loading…
Dec-23-25 09:33AM	Coty downgraded, Spruce Biosciences initiated: Wall Street's top analyst calls (The Fly)
Nov-24-25 07:00AM	Sionna Therapeutics to Participate in Upcoming December Investor Conferences (GlobeNewswire)
Nov-14-25 06:00PM	Bitdeer, Pacira BioSciences, Garrett Motion, and More Stocks See Action From Activist Investors (Barrons.com) +7.92%
Nov-05-25 07:00AM	Sionna Therapeutics Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 08:00AM	Sionna Therapeutics to Participate in Upcoming November Investor Conferences (GlobeNewswire)
Oct-31-25 05:42PM	Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors (Barrons.com) -5.63%
Oct-24-25 01:15PM	Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference (GlobeNewswire)
Oct-21-25 07:00AM	Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis (GlobeNewswire) +31.99%
Oct-01-25 04:05PM	Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference (GlobeNewswire)
Sep-15-25 12:00PM	All You Need to Know About Sionna Therapeutics, Inc. (SION) Rating Upgrade to Buy (Zacks)
09:55AM	Loading…
Sep-09-25 09:55AM	Wall Street Analysts See a 66.51% Upside in Sionna Therapeutics, Inc. (SION): Can the Stock Really Move This High? (Zacks) +13.32%
Sep-08-25 08:00AM	Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer (GlobeNewswire) -9.92%
Aug-27-25 07:00AM	Sionna Therapeutics to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Aug-25-25 07:00AM	Sionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic Fibrosis (GlobeNewswire)
Aug-11-25 07:00AM	Sionna Therapeutics Reports Second Quarter 2025 Financial Results (GlobeNewswire) +13.36%
Jun-06-25 11:00AM	Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model (GlobeNewswire) +7.42%
Jun-04-25 01:54PM	Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial (Benzinga) +9.12%
07:00AM	Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis (GlobeNewswire)
Jun-03-25 07:00AM	Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire)
May-22-25 07:00AM	Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference (GlobeNewswire)
May-12-25 07:00AM	Sionna Therapeutics Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-30-25 07:00AM	Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025 (GlobeNewswire)
Mar-20-25 07:00AM	Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-15-25 04:43PM	Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month (Insider Monkey)
Mar-06-25 10:25AM	Is Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently? (Insider Monkey) -5.04%
12:57PM	Loading…
Mar-03-25 12:57PM	Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently (Insider Monkey)
Feb-25-25 05:56AM	Sionna Therapeutics IPO: A strategic shift in the cystic fibrosis market (Pharmaceutical Technology) -13.37%
Feb-24-25 08:00AM	Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference (GlobeNewswire)
Feb-17-25 04:43PM	Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year? (Insider Monkey)
Feb-10-25 04:03PM	Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -11.04% -8.23%
Feb-06-25 07:51PM	Sionna Therapeutics Prices Upsized Initial Public Offering (GlobeNewswire)
03:13PM	Vertex challenger Sionna prices $191M IPO (BioPharma Dive)

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fitzpatrick Jennifer	Chief Legal Officer	Mar 05 '26	Option Exercise	6.11	10,250	62,628	10,250	Mar 06 06:56 PM
Fitzpatrick Jennifer	Chief Legal Officer	Mar 05 '26	Sale	33.86	10,250	347,019	0	Mar 06 06:56 PM
JENNIFER FITZPATRICK	Officer	Mar 05 '26	Proposed Sale	34.57	10,250	354,342		Mar 05 04:28 PM
Thompson Peter A.	Director	Feb 03 '26	Sale	44.58	29,063	1,295,629	3,530,702	Feb 04 07:43 PM
Thompson Peter A.	Director	Feb 02 '26	Sale	44.57	1,890	84,237	3,559,765	Feb 04 07:43 PM
ORBIMED ADVISORS LLC	Director	Feb 03 '26	Sale	44.58	29,063	1,295,629	3,530,702	Feb 04 07:39 PM
ORBIMED ADVISORS LLC	Director	Feb 02 '26	Sale	44.57	1,890	84,237	3,559,765	Feb 04 07:39 PM
TPG GP A, LLC	10% Owner	Jan 22 '26	Sale	40.00	250,000	10,000,000	6,494,962	Jan 26 05:24 PM
Rise Fund Sling, L.P.	Stockholder	Jan 22 '26	Proposed Sale	41.77	195,667	8,173,011		Jan 22 08:47 PM
Rise Fund Sling II, L.P.	Stockholder	Jan 22 '26	Proposed Sale	41.77	54,333	2,269,489		Jan 22 08:47 PM
ORBIMED ADVISORS LLC	Director	Dec 24 '25	Sale	44.55	33,356	1,486,010	3,561,655	Dec 29 08:44 PM
Thompson Peter A.	Director	Dec 24 '25	Sale	44.55	33,356	1,486,010	3,561,655	Dec 29 08:42 PM
ORBIMED ADVISORS LLC	Director	Dec 17 '25	Sale	44.50	900	40,050	3,595,986	Dec 19 07:29 PM
ORBIMED ADVISORS LLC	Director	Dec 19 '25	Sale	44.49	875	38,929	3,595,011	Dec 19 07:29 PM
ORBIMED ADVISORS LLC	Director	Dec 18 '25	Sale	44.49	100	4,449	3,595,886	Dec 19 07:29 PM
Thompson Peter A.	Director	Dec 17 '25	Sale	44.50	900	40,050	3,595,986	Dec 19 07:24 PM
Thompson Peter A.	Director	Dec 19 '25	Sale	44.49	875	38,929	3,595,011	Dec 19 07:24 PM
Thompson Peter A.	Director	Dec 18 '25	Sale	44.49	100	4,449	3,595,886	Dec 19 07:24 PM
Fitzpatrick Jennifer	Chief Legal Officer	Dec 05 '25	Option Exercise	6.11	10,250	62,628	10,250	Dec 09 04:57 PM
Fitzpatrick Jennifer	Chief Legal Officer	Dec 05 '25	Sale	40.52	10,250	415,330	0	Dec 09 04:57 PM
JENNIFER R FITZPATRICK	Officer	Dec 05 '25	Proposed Sale	40.88	10,250	419,020		Dec 05 04:27 PM
ORBIMED ADVISORS LLC	Director	Nov 24 '25	Sale	44.54	94,583	4,212,727	3,610,376	Nov 26 06:45 PM
ORBIMED ADVISORS LLC	Director	Nov 25 '25	Sale	44.60	11,890	530,294	3,598,486	Nov 26 06:45 PM
ORBIMED ADVISORS LLC	Director	Nov 26 '25	Sale	44.49	1,600	71,184	3,596,886	Nov 26 06:45 PM
Thompson Peter A.	Director	Nov 24 '25	Sale	44.54	94,583	4,212,727	3,610,376	Nov 26 06:41 PM
Thompson Peter A.	Director	Nov 25 '25	Sale	44.60	11,890	530,294	3,598,486	Nov 26 06:41 PM
Thompson Peter A.	Director	Nov 26 '25	Sale	44.49	1,600	71,184	3,596,886	Nov 26 06:41 PM
OrbiMed Private Investments VI	Shareholder	Nov 24 '25	Proposed Sale	44.38	1,047,770	46,500,033		Nov 24 08:22 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 21 '25	Sale	39.50	25,183	994,728	159,033	Nov 24 05:43 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 20 '25	Sale	40.13	5,133	205,975	166,642	Nov 24 05:43 PM
RA Capital Healthcare Fund LP	Director	Nov 21 '25	Proposed Sale	43.66	1,210	52,829		Nov 21 04:24 PM
RA Capital Nexus Fund III, L.P	Director	Nov 21 '25	Proposed Sale	43.66	6,440	281,170		Nov 21 04:21 PM
RA Capital Nexus Fund, L.P.	Director	Nov 21 '25	Proposed Sale	43.66	9,924	433,282		Nov 21 04:19 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Nov 21 '25	Proposed Sale	43.66	7,609	332,209		Nov 21 04:17 PM
RA Capital Nexus Fund III, L.P	Director	Nov 20 '25	Proposed Sale	38.94	1,313	51,128		Nov 20 04:40 PM
RA Capital Nexus Fund, L.P.	Director	Nov 20 '25	Proposed Sale	38.94	2,023	78,776		Nov 20 04:35 PM
RA Capital Healthcare Fund LP	Director	Nov 20 '25	Proposed Sale	38.94	246	9,579		Nov 20 04:34 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Nov 20 '25	Proposed Sale	38.94	1,551	60,396		Nov 20 04:30 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 17 '25	Sale	40.59	81,987	3,328,081	184,619	Nov 19 08:43 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 19 '25	Sale	40.01	47,442	1,898,173	168,193	Nov 19 08:43 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Nov 18 '25	Sale	39.57	6,922	273,904	182,527	Nov 19 08:43 PM
RA Capital Healthcare Fund LP	Director	Nov 19 '25	Proposed Sale	39.12	2,278	89,115		Nov 19 05:21 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Nov 19 '25	Proposed Sale	38.41	14,334	550,568		Nov 19 05:16 PM
RA Capital Nexus Fund, L.P.	Director	Nov 19 '25	Proposed Sale	38.41	18,696	718,113		Nov 19 05:10 PM
RA Capital Nexus Fund III, L.P	Director	Nov 19 '25	Proposed Sale	38.41	12,134	466,066		Nov 19 05:04 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Nov 18 '25	Proposed Sale	39.04	2,092	81,671		Nov 18 05:22 PM
RA Capital Nexus Fund, L.P.	Director	Nov 18 '25	Proposed Sale	39.04	2,728	106,501		Nov 18 05:17 PM
RA Capital Nexus Fund III, L.P	Director	Nov 18 '25	Proposed Sale	39.04	1,770	69,100		Nov 18 05:09 PM
RA Capital Healthcare Fund LP	Director	Nov 18 '25	Proposed Sale	39.04	332	12,961		Nov 18 04:58 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Nov 17 '25	Proposed Sale	39.93	24,772	989,146		Nov 17 05:12 PM
RA Capital Nexus Fund, L.P.	Director	Nov 17 '25	Proposed Sale	39.93	32,310	1,290,138		Nov 17 05:04 PM
RA Capital Nexus Fund III, L.P	Director	Nov 17 '25	Proposed Sale	39.93	20,969	837,292		Nov 17 04:56 PM
RA Capital Healthcare Fund LP	Director	Nov 17 '25	Proposed Sale	39.93	3,936	157,164		Nov 17 04:46 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Oct 24 '25	Sale	39.50	311,000	12,284,500	219,867	Oct 28 09:05 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Oct 28 '25	Sale	39.58	62,610	2,478,104	209,391	Oct 28 09:05 PM
RA Capital Nexus Fund III, L.P	Director	Oct 28 '25	Proposed Sale	39.45	17,118	675,305		Oct 28 05:13 PM
RA Capital Healthcare Fund LP	Director	Oct 28 '25	Proposed Sale	39.45	3,624	142,967		Oct 28 05:07 PM
RA Capital Nexus Fund, L.P.	Director	Oct 28 '25	Proposed Sale	39.45	31,392	1,238,414		Oct 28 05:05 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Oct 28 '25	Proposed Sale	39.45	10,476	413,278		Oct 28 04:57 PM
RA Capital Nexus Fund, L.P.	Director	Oct 24 '25	Proposed Sale	39.21	122,271	4,794,246		Oct 24 06:05 PM
RA Capital Nexus Fund III, L.P	Director	Oct 24 '25	Proposed Sale	39.21	66,672	2,614,209		Oct 24 06:00 PM
RA Capital Healthcare Fund LP	Director	Oct 24 '25	Proposed Sale	39.21	14,116	553,488		Oct 24 05:53 PM
BLACKWELL PARTNERS LLC - SERIE	Director	Oct 24 '25	Proposed Sale	39.21	107,941	4,232,367		Oct 24 05:39 PM
Cloonan Michael	President & CEO	Oct 21 '25	Option Exercise	6.11	99,800	609,778	580,875	Oct 22 05:39 PM
Cloonan Michael	President & CEO	Oct 21 '25	Sale	36.26	99,800	3,618,560	547,343	Oct 22 05:39 PM
Booth Bruce	Director	Oct 21 '25	Sale	34.22	88,878	3,041,683	686,567	Oct 21 05:12 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 21 '25	Proposed Sale	32.20	15,418	496,460		Oct 21 04:22 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 21 '25	Proposed Sale	32.20	73,460	2,365,412		Oct 21 04:21 PM
MICHAEL CLOONAN	Director	Oct 21 '25	Proposed Sale	32.20	99,800	3,213,560		Oct 21 04:19 PM
Booth Bruce	Director	Oct 16 '25	Sale	32.35	169,260	5,476,168	722,301	Oct 20 09:39 PM
Booth Bruce	Director	Oct 17 '25	Sale	32.37	61,124	1,978,323	711,697	Oct 20 09:39 PM
Booth Bruce	Director	Oct 20 '25	Sale	32.09	55,985	1,796,611	701,985	Oct 20 09:39 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 20 '25	Proposed Sale	31.93	46,273	1,477,497		Oct 20 04:46 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 20 '25	Proposed Sale	31.93	9,712	310,104		Oct 20 04:46 PM
Cloonan Michael	President & CEO	Oct 15 '25	Option Exercise	6.11	14,775	90,275	562,118	Oct 17 05:11 PM
Cloonan Michael	President & CEO	Oct 16 '25	Option Exercise	6.11	10,425	63,697	557,568	Oct 17 05:11 PM
Cloonan Michael	President & CEO	Oct 15 '25	Sale	31.11	14,775	459,662	547,343	Oct 17 05:11 PM
Cloonan Michael	President & CEO	Oct 16 '25	Sale	31.51	10,425	328,491	547,343	Oct 17 05:11 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 17 '25	Proposed Sale	32.71	10,604	346,857		Oct 17 04:27 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 17 '25	Proposed Sale	32.72	50,520	1,653,014		Oct 17 04:27 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 16 '25	Proposed Sale	30.91	139,897	4,324,216		Oct 16 05:01 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 16 '25	Proposed Sale	30.91	29,363	907,610		Oct 16 05:00 PM
MICHAEL CLOONAN	Director	Oct 16 '25	Proposed Sale	30.91	200	6,182		Oct 16 04:34 PM
Booth Bruce	Director	Oct 15 '25	Sale	30.61	115,856	3,545,798	751,664	Oct 15 06:33 PM
Booth Bruce	Director	Oct 13 '25	Sale	30.38	58,232	1,769,101	771,867	Oct 15 06:33 PM
Booth Bruce	Director	Oct 10 '25	Sale	29.98	20,238	606,735	781,969	Oct 15 06:33 PM
Booth Bruce	Director	Oct 14 '25	Sale	29.95	606	18,150	771,762	Oct 15 06:33 PM
MICHAEL CLOONAN	Director	Oct 15 '25	Proposed Sale	29.94	25,000	748,500		Oct 15 04:38 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 13 '25	Proposed Sale	29.42	48,130	1,415,985		Oct 14 04:23 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 13 '25	Proposed Sale	29.42	10,102	297,201		Oct 14 04:22 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 10 '25	Proposed Sale	28.35	3,511	99,537		Oct 10 04:24 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 10 '25	Proposed Sale	28.35	16,727	474,210		Oct 10 04:24 PM
Booth Bruce	Director	Oct 03 '25	Sale	30.00	37,746	1,132,380	787,527	Oct 07 05:00 PM
Booth Bruce	Director	Oct 06 '25	Sale	29.95	11,800	353,410	785,480	Oct 07 05:00 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 06 '25	Proposed Sale	30.01	2,047	61,430		Oct 06 04:51 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 06 '25	Proposed Sale	30.01	9,753	292,688		Oct 06 04:51 PM
Atlas Venture Opportunity Fund	Shareholder	Oct 03 '25	Proposed Sale	29.30	6,548	191,856		Oct 03 04:44 PM
Atlas Venture Fund XI, LP	Shareholder	Oct 03 '25	Proposed Sale	29.30	31,198	914,101		Oct 03 04:44 PM
Booth Bruce	Director	Sep 29 '25	Sale	30.09	66,105	1,989,099	796,259	Oct 01 06:04 PM
Booth Bruce	Director	Sep 30 '25	Sale	30.06	12,388	372,383	794,110	Oct 01 06:04 PM

Open in Screener

LTH

Life Time Group Holdings Inc

Mar 12 • 03:08PM ET

25.95

-0.69 -2.61 %

Consumer Cyclical • Leisure • USA • NYSE

LTH Life Time Group Holdings Inc daily Stock Chart

Peers: PLNT HAS MTN FUN CCL CSV CWH RICK MCW TH

| Held by: VTI IWM VB VBK VXF IWO AVUV FESM DFAT VTWO

Index	RUT	P/E	15.67	EPS (ttm)	1.66	Insider Own	31.34%	Shs Outstand	221.08M	Perf Week	-0.67%
Market Cap	5.75B	Forward P/E	15.41	EPS next Y	1.68	Insider Trans	-18.70%	Shs Float	152.28M	Perf Month	-13.11%
Enterprise Value	9.72B	PEG	4.86	EPS next Q	0.33	Inst Own	63.77%	Short Float	5.12%	Perf Quarter	1.75%
Income	373.67M	P/S	1.92	EPS this Y	-12.58%	Inst Trans	-0.36%	Short Ratio	3.30	Perf Half Y	-8.96%
Sales	3.00B	P/B	1.83	EPS next Y	16.06%	ROA	4.45%	Short Interest	7.80M	Perf YTD	-2.39%
Book/sh	14.14	P/C	24.79	EPS next 5Y	3.17%	ROE	13.03%	52W High	34.99 -25.85%	Perf Year	-8.99%
Cash/sh	1.05	P/FCF	-	EPS past 3/5Y	- -	ROIC	5.18%	52W Low	24.14 7.48%	Perf 3Y	50.41%
Dividend Est.	-	EV/EBITDA	12.30	Sales past 3/5Y	18.01% 25.86%	Gross Margin	35.97%	Volatility	4.11% 3.93%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.24	EPS Y/Y TTM	120.81%	Oper. Margin	16.48%	ATR (14)	1.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.52	Sales Y/Y TTM	14.28%	Profit Margin	12.48%	RSI (14)	39.59	Recom	1.12
Dividend Gr. 3/5Y	- -	Current Ratio	0.63	EPS Q/Q	221.58%	SMA20	-5.42%	Beta	1.69	Target Price	40.00
Payout	0.00%	Debt/Eq	1.34	Sales Q/Q	12.33%	SMA50	-7.37%	Rel Volume	1.00	Prev Close	26.64
Employees	44000	LT Debt/Eq	1.31	Earnings	Feb 24 BMO	SMA200	-6.11%	Avg Volume	2.36M	Price	25.95
IPO	Oct 07, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	93.76% 0.54%	Trades		Volume	2,072,621	Change	-2.61%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Initiated	KeyBanc Capital Markets	Overweight	$40
Mar-11-26	Initiated	Wells Fargo	Overweight	$37
Mar-10-26	Initiated	Jefferies	Buy	$40
Oct-27-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$39
Oct-17-25	Initiated	UBS	Buy	$43
May-23-25	Resumed	Craig Hallum	Buy	$45
Nov-22-24	Initiated	Evercore ISI	Outperform	$29
Jul-19-24	Initiated	Craig Hallum	Buy	$30
Apr-23-24	Initiated	Northland Capital	Outperform	$23
Oct-04-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$17
Sep-27-23	Resumed	Morgan Stanley	Equal-Weight	$18
Aug-11-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$15 → $13
Nov-01-21	Initiated	Wells Fargo	Equal Weight	$19
Nov-01-21	Initiated	RBC Capital Mkts	Outperform	$21
Nov-01-21	Initiated	Oppenheimer	Outperform	$40
Nov-01-21	Initiated	Morgan Stanley	Equal-Weight	$21
Nov-01-21	Initiated	Mizuho	Buy	$24
Nov-01-21	Initiated	Guggenheim	Buy	$21
Nov-01-21	Initiated	Goldman	Neutral	$23
Nov-01-21	Initiated	Deutsche Bank	Buy	$21

Show Previous Ratings

Today 09:50AM	CVS upgraded, General Mills downgraded: Wall Street's top analyst calls (The Fly)
Mar-10-26 09:34AM	Qualcomm downgraded, Rivian upgraded: Wall Street's top analyst calls (The Fly)
Mar-06-26 06:39PM	Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600 (PR Newswire) +6.82%
Mar-02-26 05:31PM	HIGHLIGHTS: World Gym Fireside Chat with President John Caraccio & Exec Committee Member Mark Harms (Exec Edge)
09:37AM	REPLAY: World Gym Fireside Chat with President John Caraccio & Exec Committee Member Mark Harms (Exec Edge)
03:24PM	Loading…
Mar-01-26 03:24PM	Thousands of Runners Complete Sold-Out Life Time 305 Half Marathon & 5K (PR Newswire)
Feb-28-26 08:04AM	Life Time Group Holdings, Inc. (LTH): A Bull Case Theory (Insider Monkey)
Feb-25-26 10:06AM	World Gym Fireside Chat with President John Caraccio on Friday Feb 27 at 8AM EST (Exec Edge)
03:12AM	Life Time Group Q4 Earnings Call Highlights (MarketBeat)
Feb-24-26 08:07PM	Life Time Group Holdings, Inc. Q4 2025 Earnings Call Summary (Moby)
04:03PM	Life Time Group Holdings Inc (LTH) Q4 2025 Earnings Call Highlights: Record Revenue and ... (GuruFocus.com)
09:30AM	Life Time Group Holdings (LTH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:50AM	Life Time Group Holdings, Inc. (LTH) Q4 Earnings and Revenues Top Estimates (Zacks)
07:35AM	World Gym Corp Posts 16% Surge in 2025 Profit, Declares Dividend (Exec Edge)
06:45AM	Life Time Reports Fourth Quarter and Full-Year 2025 Financial Results (PR Newswire)
07:18AM	Loading…
Feb-23-26 07:18AM	What To Expect From Life Time Group Holdings Inc (LTH) Q4 2025 Earnings (GuruFocus.com)
Feb-19-26 10:00AM	Earnings Preview: Marcus (MCS) Q4 Earnings Expected to Decline (Zacks)
Feb-18-26 03:00PM	Life Time Ignites the Pilates and Reformer Boom as Demand Surges Coast to Coast (PR Newswire)
Feb-17-26 06:05PM	Caesars Entertainment (CZR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
10:00AM	Life Time Group Holdings, Inc. (LTH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Feb-11-26 08:00AM	Life Time Foundation Announces Move for a Life Time, the Next Chapter of its Annual Children's Health Fundraiser (PR Newswire)
Feb-10-26 01:20PM	Life Time Opens First Athletic Country Club of 2026 in West Cary - its Fourth in the Raleigh-Cary Market - Further Addressing Rapidly Growing Demand for Healthy Living (PR Newswire)
Feb-05-26 04:47PM	What Is Fibermaxxing? Life Time Experts Share Simple, Safe Ways to Add More Fiber Daily (PR Newswire)
Feb-04-26 08:00AM	Life Time to Report Fourth Quarter and Full-Year 2025 Financial Results on February 24, 2026 (PR Newswire)
Feb-02-26 02:52PM	Life Time Highlights Eight Science-Baked Heart-Health Actions during American Heart Month (PR Newswire)
Jan-25-26 08:51PM	Life Time Miami Marathon & Half Delivers an Unforgettable Weekend for More Than 17,000 Runners (PR Newswire)
Jan-24-26 08:50AM	Life Time Group price target raised to $42 from $41 at Northland (TipRanks)
Jan-23-26 03:47PM	Running for More than the Finish Line: Life Time Foundation Invests in Miami's Future During Marathon Weekend (PR Newswire)
Jan-22-26 06:45AM	Life Time Reports Preliminary Estimated Fourth Quarter and Full-Year 2025 Financial Results and Introduces Select Fiscal 2026 Guidance (PR Newswire)
Jan-16-26 05:11PM	Where Endurance Meets Lifestyle: Life Time Announces 2026 Athletic Events Calendar (PR Newswire)
02:30PM	Loading…
Jan-15-26 02:30PM	Sporty, Styled Up: Category Leaders Life Time and EVEREVE Unveil Exclusive Capsule Collection Designed for Real Life; Available January 22 (PR Newswire)
Jan-05-26 08:46AM	Are Options Traders Betting on a Big Move in Life Time Group Stock? (Zacks)
Dec-31-25 07:01AM	Life Time Opens Fifth Austin Athletic Country Club on December 31, Expanding in One of America's Fastest-Growing Metros (PR Newswire)
Dec-30-25 02:02PM	2026 Life Time Wellness Survey Results Are In: Strength Training and Longevity Lead New Year Priorities with 82% Focused More on Wellbeing (PR Newswire)
Dec-26-25 11:40AM	LTH vs. ATAT: Which Stock Is the Better Value Option? (Zacks)
Dec-19-25 05:09AM	Life Time Opens Adults-Only Club in Uptown Boca on December 19; First Florida Location to Offer Coveted Athletic Reformer Class, CTR (PR Newswire)
Dec-17-25 09:40AM	Are Consumer Discretionary Stocks Lagging Life Time Group Holdings (LTH) This Year? (Zacks)
Dec-15-25 08:00AM	Life Time Opens Otay Ranch Athletic Country Club in Chula Vista, California Anchoring One of San Diego's Fastest-Growing Communities (PR Newswire)
Dec-12-25 09:55AM	Does Life Time Group Holdings (LTH) Have the Potential to Rally 54.09% as Wall Street Analysts Expect? (Zacks)
Dec-11-25 02:32PM	Life Time Reveals Top Last-Minute Gifts for the Health-Aficionados (PR Newswire)
Dec-10-25 11:40AM	LTH vs. ATAT: Which Stock Should Value Investors Buy Now? (Zacks)
Dec-04-25 03:58PM	Life Time's Hybrid Athlete Competition Returns in 2026: LT Games Presented by Ten Thousand Set for April in Minneapolis (PR Newswire)
Dec-02-25 10:02AM	Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve (Zacks)
Dec-01-25 02:25PM	LIFE TIME SIGNS LEASE AT 175 THIRD STREET, THE NEWEST DEVELOPMENT IN CHARNEY COMPANIES AND TAVROS' GOWANUS WHARF (PR Newswire)
09:40AM	Is Life Time Group Holdings (LTH) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
08:02AM	4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026 (Zacks)
Nov-27-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Life Time Group Holdings (LTH) (Zacks)
Nov-26-25 09:55AM	Wall Street Analysts Predict a 46.55% Upside in Life Time Group Holdings (LTH): Here's What You Should Know (Zacks)
Nov-24-25 11:40AM	LTH or ATAT: Which Is the Better Value Stock Right Now? (Zacks)
09:11AM	Best Health & Fitness Stocks for Investors Betting on Wellness (Zacks)
Nov-21-25 09:05AM	Life Time Experts Share What to Look for in a Creatine Supplement -- Beware of Hype and Focus on Purity and Proof (PR Newswire)
Nov-13-25 09:40AM	Are Consumer Discretionary Stocks Lagging Life Time Group Holdings (LTH) This Year? (Zacks)
09:15AM	Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-12-25 12:00PM	Life Time Group Holdings (LTH) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
06:44AM	New Strong Buy Stocks for November 12th (Zacks)
Nov-11-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Life Time Group Holdings (LTH) (Zacks)
08:26AM	4 Value Stocks With Strong Interest Coverage as Markets Rebound (Zacks)
Nov-07-25 11:40AM	LTH vs. ATAT: Which Stock Is the Better Value Option? (Zacks)
Nov-06-25 10:53AM	Life Time Expands CTR Reformer Workout Nationwide Amid Soaring Demand (PR Newswire)
Nov-05-25 09:55AM	How Much Upside is Left in Life Time Group Holdings (LTH)? Wall Street Analysts Think 49.85% (Zacks)
09:11AM	Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks)
08:58AM	NCLH Q3 Earnings Buoyed by Record Bookings and Strong Demand (Zacks)
Nov-04-25 04:17PM	Life Time Group Holdings Inc (LTH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +5.27%
11:05AM	Norwegian Q3 Earnings Beat, Revenues Miss Estimates, Stock Down (Zacks)
09:30AM	Compared to Estimates, Life Time Group Holdings (LTH) Q3 Earnings: A Look at Key Metrics (Zacks)
08:00AM	Life Time Group Holdings, Inc. (LTH) Beats Q3 Earnings and Revenue Estimates (Zacks)
06:45AM	Life Time Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-03-25 07:24AM	Life Time Group Holdings Inc (LTH) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-30-25 09:39PM	Morgan Stanley Upgrades Life Time Group Holdings (LTH) Stock to Overweight from Equal Weight (Insider Monkey)
01:59PM	It's Coming Nov. 2-Beat the Upcoming Daylight Savings Slump with These Six Expert Tips from Life Time's Chief Science Officer Jim LaValle (PR Newswire)
10:00AM	Planet Fitness (PLNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-28-25 01:50PM	327 Luxury Life Time Living Wellness Residences to be Part of PV Development in Phoenix, Arizona (PR Newswire)
Oct-27-25 04:05PM	Lauren Weeks and Noah Ohlsen Crowned Champions at Life Time's Inaugural LT Games Presented by Ten Thousand in Minneapolis (PR Newswire)
Oct-24-25 05:30PM	Hershey vs. Mondelez: Which candy stocks are sweet as prices rise (Yahoo Finance Video)
Oct-23-25 01:00PM	Life Time Unveils 2026 Grand Prix Series (PR Newswire)
Oct-20-25 04:38PM	Lea Jansen and Christopher Haworth Crowned Champions at Life Time's Inaugural LT Open, Each Taking Home $50,000 (PR Newswire)
Oct-17-25 05:05AM	Life Time Launches a New Era of Luxury Wellness at Iconic Prudential Center with October 17 Opening of Urban Athletic Country Club (PR Newswire)
Oct-15-25 03:15PM	Fans Invited to Experience the LT Open - Nation's First-Ever Elite Singles-Only Pickleball Tournament in Atlanta Oct. 17-19 (PR Newswire)
Oct-10-25 08:03AM	Just 90 Minutes for Lasting Impact: Join Life Time's GO90 Workout to Support ALS Research and Children's Health on October 25 (PR Newswire)
Oct-09-25 02:46PM	Life Time to Report Third Quarter 2025 Financial Results on November 4, 2025 (PR Newswire)
Oct-08-25 09:02AM	The Hottest Fitness Trend Just Went Luxe: Life Time and Aion Forge Strategic Partnership to Bring Weighted Vests to Millions (PR Newswire)
Sep-29-25 10:25AM	Carnival (CCL) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Sep-25-25 09:00AM	Life Time Foundation Empowers Schools to Serve Healthier Meals with Complimentary Green Onion Online Tool (PR Newswire)
Sep-19-25 03:26PM	Dianthus, Opendoor, and More Stocks See Action From Activist Investors (Barrons.com)
Sep-18-25 11:45AM	Life Time Announces 2nd Annual 30 Strong Challenge to Help Members Build Healthy Fall Habits: Registration Open for Oct. 6 Kickoff (PR Newswire)
Sep-09-25 09:15AM	Introducing a New Standard in Hybrid Athlete Competition: Life Time Debuts LT Games Presented by Ten Thousand Oct. 25-26 in Minneapolis; Registration Now Open (PR Newswire)
Aug-25-25 10:17AM	From Desk to Deadlift: Life Time Redefines the Office with More Than 55 New In-Club Work Lounges Nationwide (PR Newswire)
Aug-20-25 02:45PM	Life Time Disrupts Sleep Supplement Market with Launch of LTH Dream: Melatonin-Free Formula Backed by Clinical Research (PR Newswire)
Aug-16-25 11:56PM	Life Time Group Holdings, Inc. (LTH): A Bull Case Theory (Insider Monkey)
Aug-15-25 01:04PM	For Fifth Straight Year, Iconic Life Time Miami Marathon Sells Out in Record Time; Waitlist Now Open for January 25, 2026, Event (PR Newswire)
Aug-08-25 08:00AM	Life Time Opens Ninth Atlanta-Area Athletic Country Club on August 8, Transforming Former Concourse Athletic Club into Life Time Perimeter (PR Newswire)
Aug-06-25 03:19AM	Life Time Group Holdings Inc (LTH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Aug-05-25 07:55AM	Life Time Group Holdings, Inc. (LTH) Q2 Earnings and Revenues Surpass Estimates (Zacks) -9.65%
06:45AM	Life Time Reports Second Quarter 2025 Financial Results (PR Newswire)
Aug-04-25 09:25AM	What To Expect From Life Time Group Holdings Inc (LTH) Q2 2025 Earnings (GuruFocus.com)
Aug-01-25 07:00AM	LT Pro 48 Pickleball Named Official Ball of Carvana PPA Tour (PR Newswire)
Jul-29-25 04:15PM	Life Time Launches Complimentary AI Health Companion for Everyone: "Just Ask L•AI•C" (PR Newswire)
07:45AM	Royal Caribbean (RCL) Beats Q2 Earnings Estimates (Zacks)
Jul-22-25 10:00AM	Life Time Announces Groundbreaking Singles Pickleball Tournament in October - LT Open - with $250,000 Prize Purse (PR Newswire)
Jul-21-25 04:31PM	Marine, Mom of Four, Pastry Chef Among Five Winners in Life Time's First-Ever 60XT Wellness Challenge (PR Newswire)

Life Time Group Holdings, Inc. operates as a holding company through its subsidiaries operates professional fitness, family recreation and spa centers. It is primarily engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation and spa centers in a resort-like environment, principally in residential locations of major metropolitan areas in the United States and Canada. The company was founded by Bahram Akradi in 1992 and is headquartered in Chanhassen, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Weaver Erik	EVP & Chief Financial Officer	Mar 03 '26	Sale	25.73	1,329	34,193	136,166	Mar 03 07:24 PM
Weaver Erik	Officer	Mar 03 '26	Proposed Sale	25.73	1,329	34,193		Mar 03 04:02 PM
Weaver Erik	EVP & Chief Financial Officer	Feb 03 '26	Sale	29.90	1,493	44,647	77,771	Feb 03 06:30 PM
Singh Ritadhwaja Jebens	EVP & CHIEF DIGITAL OFFICER	Feb 03 '26	Sale	30.31	5,880	178,223	102,144	Feb 03 06:30 PM
Weaver Erik	Officer	Feb 03 '26	Proposed Sale	29.90	1,493	44,647		Feb 03 03:09 PM
Singh Ritadhwaja Jebens	Officer	Feb 03 '26	Proposed Sale	30.31	5,880	178,223		Feb 03 11:32 AM
Singh Ritadhwaja Jebens	EVP & CHIEF DIGITAL OFFICER	Jan 23 '26	Sale	29.75	12,088	359,618	110,967	Jan 27 04:36 PM
Singh Ritadhwaja Jebens	Officer	Jan 23 '26	Proposed Sale	29.75	12,088	359,618		Jan 23 04:45 PM
Buss Eric J	EVP & CHIEF ADMIN. OFFICER	Nov 26 '25	Option Exercise	10.00	162,722	1,627,220	543,405	Dec 01 04:33 PM
Buss Eric J	EVP & CHIEF ADMIN. OFFICER	Nov 28 '25	Option Exercise	10.00	74,487	744,870	455,170	Dec 01 04:33 PM
Buss Eric J	EVP & CHIEF ADMIN. OFFICER	Nov 26 '25	Sale	28.04	162,722	4,562,383	380,683	Dec 01 04:33 PM
Buss Eric J	EVP & CHIEF ADMIN. OFFICER	Nov 28 '25	Sale	28.05	74,487	2,089,427	380,683	Dec 01 04:33 PM
Buss Eric J	Officer	Nov 28 '25	Proposed Sale	28.05	74,487	2,089,427		Nov 28 01:34 PM
Buss Eric J	Officer	Nov 26 '25	Proposed Sale	28.04	162,722	4,562,381		Nov 26 04:13 PM
Weaver Erik	EVP & Chief Financial Officer	Oct 13 '25	Sale	25.10	4,846	121,625	81,765	Oct 14 04:32 PM
Weaver Erik	Officer	Oct 13 '25	Proposed Sale	25.10	4,846	121,627		Oct 14 07:35 AM
Partners Group Private Equity	Member of 10% Owner Group	Sep 11 '25	Sale	28.95	745,707	21,588,218	3,720,500	Sep 15 05:00 PM
DANHAKL JOHN G	Director	Sep 11 '25	Sale	28.95	4,991,976	144,517,705	24,906,061	Sep 15 05:00 PM
Green LTF Holdings II LP	Director	Sep 11 '25	Sale	28.95	4,991,976	144,517,705	41,415	Sep 15 05:00 PM
Galashan John Kristofer	Director	Sep 11 '25	Sale	28.95	4,991,976	144,517,705	24,906,061	Sep 15 05:00 PM
Partners Group Series Access I	Stockholder	Sep 11 '25	Proposed Sale	29.38	325,061	9,550,292		Sep 11 09:05 PM
Partners Group Access 83 PF LP	Stockholder	Sep 11 '25	Proposed Sale	29.38	27,100	796,198		Sep 11 09:02 PM
Partners Group Private Equity	Stockholder	Sep 11 '25	Proposed Sale	29.38	863	25,355		Sep 11 08:59 PM
Partners Group Private Equity	Stockholder	Sep 11 '25	Proposed Sale	29.38	392,683	11,537,027		Sep 11 08:54 PM
TPG VII Magni SPV, L.P.	Stockholder	Sep 11 '25	Proposed Sale	29.38	3,123,218	91,760,145		Sep 11 08:52 PM
TPG Lonestar I, L.P.	Stockholder	Sep 11 '25	Proposed Sale	29.38	21,688	637,193		Sep 11 08:51 PM
LGP Associates VI-B LLC	Stockholder	Sep 11 '25	Proposed Sale	29.38	82,730	2,430,607		Sep 11 08:51 PM
TPG VII Magni Co-Invest, L.P.	Stockholder	Sep 11 '25	Proposed Sale	29.38	428,930	12,601,963		Sep 11 08:51 PM
LGP Associates VI-A LLC	Stockholder	Sep 11 '25	Proposed Sale	29.38	8,301	243,883		Sep 11 08:48 PM
Green LTF Holdings II LP	Stockholder	Sep 11 '25	Proposed Sale	29.38	4,900,945	143,989,764		Sep 11 08:45 PM
Javaheri Parham	EVP &PRESIDENT CLUB OPERATIONS	Aug 26 '25	Sale	28.05	9,375	262,933	240,151	Aug 28 04:58 PM
PARHAM JAVAHERI	Officer	Aug 26 '25	Proposed Sale	28.05	9,375	262,932		Aug 26 04:04 PM
Javaheri Parham	EVP &PRESIDENT CLUB OPERATIONS	Jun 12 '25	Sale	27.84	84,744	2,359,180	249,526	Jun 16 04:28 PM
PARHAM JAVAHERI	Officer	Jun 12 '25	Proposed Sale	27.84	84,744	2,359,171		Jun 12 04:18 PM
Weaver Erik	EVP & Chief Financial Officer	Jun 06 '25	Sale	28.74	18,000	517,338	86,611	Jun 10 04:52 PM
Singh Ritadhwaja Jebens	EVP & CHIEF DIGITAL OFFICER	Jun 06 '25	Option Exercise	11.48	80,000	918,400	267,436	Jun 10 04:51 PM
Singh Ritadhwaja Jebens	EVP & CHIEF DIGITAL OFFICER	Jun 06 '25	Sale	28.80	134,247	3,866,018	133,189	Jun 10 04:51 PM
DANHAKL JOHN G	Director	Jun 06 '25	Sale	29.38	11,655,582	342,440,999	29,898,037	Jun 10 04:15 PM
Green LTF Holdings II LP	Director	Jun 06 '25	Sale	29.38	11,655,582	342,440,999	49,716	Jun 10 04:15 PM
Galashan John Kristofer	Director	Jun 06 '25	Sale	29.38	11,655,582	342,440,999	29,898,037	Jun 10 04:15 PM
TPG GP A, LLC	Former 10% Owner	Jun 06 '25	Sale	29.38	8,344,418	245,159,001	21,404,488	Jun 10 04:15 PM
RITADHWAJA SINGH	Officer	Jun 06 '25	Proposed Sale	28.80	134,247	3,866,013		Jun 06 04:34 PM
ERIK WEAVER	Officer	Jun 06 '25	Proposed Sale	28.74	18,000	517,331		Jun 06 04:10 PM

Open in Screener

CBLL

Ceribell Inc

Mar 12 • 03:08PM ET

18.34

-0.18 -0.94 %

Healthcare • Medical Devices • USA • NASD

Held by: VTI IWM VXF IWO VTWO SCHA LFSC ITOT IWC VHT

Index	RUT	P/E	-	EPS (ttm)	-1.46	Insider Own	36.12%	Shs Outstand	37.49M	Perf Week	2.54%
Market Cap	690.53M	Forward P/E	-	EPS next Y	-1.01	Insider Trans	-3.72%	Shs Float	24.04M	Perf Month	-11.76%
Enterprise Value	553.55M	PEG	-	EPS next Q	-0.39	Inst Own	61.40%	Short Float	8.01%	Perf Quarter	-13.55%
Income	-53.41M	P/S	7.75	EPS this Y	0.26%	Inst Trans	5.29%	Short Ratio	5.19	Perf Half Y	60.36%
Sales	89.06M	P/B	4.43	EPS next Y	30.90%	ROA	-25.36%	Short Interest	1.93M	Perf YTD	-16.35%
Book/sh	4.14	P/C	4.34	EPS next 5Y	16.28%	ROE	-30.83%	52W High	24.33 -24.60%	Perf Year	-14.91%
Cash/sh	4.23	P/FCF	-	EPS past 3/5Y	-10.19% -	ROIC	-30.26%	52W Low	10.01 83.27%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	50.90% -	Gross Margin	87.89%	Volatility	4.24% 4.70%	Perf 5Y	-
Dividend TTM	-	EV/Sales	6.22	EPS Y/Y TTM	-	Oper. Margin	-65.57%	ATR (14)	0.90	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.24	Sales Y/Y TTM	-	Profit Margin	-59.97%	RSI (14)	40.26	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.61	EPS Q/Q	-3.59%	SMA20	-3.33%	Beta	1.07	Target Price	27.86
Payout	-	Debt/Eq	0.14	Sales Q/Q	33.72%	SMA50	-10.68%	Rel Volume	1.39	Prev Close	18.52
Employees	327	LT Debt/Eq	0.14	Earnings	Feb 24 AMC	SMA200	12.25%	Avg Volume	370.68K	Price	18.34
IPO	Oct 11, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.64% 3.58%	Trades		Volume	450,413	Change	-0.94%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-25	Initiated	Raymond James	Strong Buy	$19
Jun-24-25	Initiated	BTIG Research	Buy	$30
Apr-04-25	Initiated	Ladenburg Thalmann	Buy	$32
Nov-05-24	Initiated	William Blair	Outperform
Nov-05-24	Initiated	TD Cowen	Buy	$31
Nov-05-24	Initiated	JP Morgan	Overweight	$32
Nov-05-24	Initiated	Canaccord Genuity	Buy	$30
Nov-05-24	Initiated	BofA Securities	Buy	$32

Mar-07-26 11:15AM	CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium (MarketBeat)
10:23AM	CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot (MarketBeat)
Mar-02-26 10:23AM	Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord (Insider Monkey)
Feb-25-26 12:03AM	CeriBell Inc (CBLL) Q4 2025 Earnings Call Highlights: Revenue Surge and Market Expansion Amid ... (GuruFocus.com)
Feb-24-26 10:06PM	CeriBell Q4 Earnings Call Highlights (MarketBeat)
09:55PM	Loading…
09:55PM	CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
08:03PM	CeriBell, Inc. Q4 2025 Earnings Call Summary (Moby)
04:05PM	Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-23-26 07:26AM	CeriBell Inc (CBLL) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-18-26 04:05PM	Ceribell to Participate in Upcoming March Investor Conferences (GlobeNewswire)
Feb-10-26 04:05PM	Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (GlobeNewswire)
Jan-14-26 09:21AM	CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion (MarketBeat)
Jan-06-26 12:34PM	CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection (Zacks)
Jan-05-26 08:00AM	Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution (GlobeNewswire)
Dec-30-25 04:05PM	Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
10:02AM	Loading…
Dec-12-25 10:02AM	CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution (Zacks)
09:49AM	AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs (PR Newswire)
Dec-09-25 08:00AM	Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution (GlobeNewswire)
Nov-24-25 08:00AM	Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates (GlobeNewswire)
Nov-19-25 04:05PM	Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-06-25 04:05PM	Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-05-25 12:06AM	CeriBell Inc (CBLL) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) +7.88%
Nov-04-25 06:05PM	CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Ceribell Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-29-25 10:00AM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know (Zacks) -6.24%
Oct-28-25 10:00AM	CeriBell, Inc. (CBLL) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-21-25 04:05PM	Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 (GlobeNewswire) +7.04%
Sep-22-25 08:00AM	Medtech Leader Erica Rogers Joins Ceribell Board of Directors (GlobeNewswire)
Aug-13-25 12:08PM	J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT (Insider Monkey)
Aug-05-25 04:05PM	Ceribell Reports Second Quarter 2025 Financial Results (GlobeNewswire) -15.25%
04:05PM	Loading…
Jul-29-25 04:05PM	Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
03:20PM	Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival (Bloomberg)
Jul-22-25 04:05PM	Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025 (GlobeNewswire)
Jul-07-25 04:42PM	Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware (GlobeNewswire) -9.14%
Jun-20-25 09:11AM	AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape (PR Newswire)
May-29-25 05:44AM	The medtech IPO window is finally open. Or is it? (MedTech Dive)
May-20-25 04:05PM	Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference (GlobeNewswire)
May-09-25 03:43AM	CeriBell Inc (CBLL) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... (GuruFocus.com) -6.61%
May-08-25 04:05PM	Ceribell Reports First Quarter 2025 Financial Results (GlobeNewswire) +6.81%
Apr-30-25 04:05PM	Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference (GlobeNewswire)
08:00AM	Ceribell Receives FedRAMP High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems (GlobeNewswire)
Apr-24-25 04:05PM	Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Apr-23-25 02:58PM	TimesSquare U.S. Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-21-25 05:00AM	Ceribell wins FDA nod for algorithm to detect pediatric seizures (MedTech Dive)
Apr-16-25 10:40AM	CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm (Zacks)
Apr-15-25 08:00AM	FDA Clears Ceribell's Clarity Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older (GlobeNewswire)
Apr-07-25 01:04PM	CeriBell's IPO Lockup Ends April 9 - Here's Why We're Shorting It Today (Seeking Alpha)
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
Feb-26-25 02:15AM	CeriBell Inc (CBLL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... (GuruFocus.com)
Feb-25-25 04:05PM	Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-18-25 04:05PM	Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference (GlobeNewswire)
Feb-11-25 04:05PM	Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 (GlobeNewswire)
Dec-23-24 04:05PM	Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-19-24 08:00AM	Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing (GlobeNewswire)
07:01AM	Meet the biophysicist whose seizure-detection company is using AI to get a better read on peoples brains (FastCompany)
Nov-13-24 11:55PM	Ceribell, Inc. Reports Strong Q3 2024 Growth (TipRanks)
Nov-12-24 04:05PM	Ceribell Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 08:00AM	Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs (GlobeNewswire)
Nov-07-24 04:05PM	Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-06-24 06:31AM	Ceribell initiated with a Buy at BofA on differentiated AI algorithm (TipRanks)
Oct-29-24 04:05PM	Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 (PR Newswire)
Oct-18-24 01:01AM	TPG GP A, LLC Acquires New Stake in CeriBell Inc (GuruFocus.com)
Oct-16-24 04:05PM	New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG (PR Newswire)
Oct-15-24 05:00PM	CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
Oct-14-24 06:45AM	Opening Day: Another trio of biotech IPOs make Friday debut (TipRanks)
Oct-11-24 05:00PM	CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs (Bloomberg)
10:15AM	CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq (FastCompany)
08:45AM	Upstream Bio Leads Life Sciences IPOs With Upsized Listing (Bloomberg)
Oct-10-24 11:27PM	CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering (PR Newswire)

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Foehr David	Senior VP, Finance and PAO	Mar 03 '26	Option Exercise	4.70	4,560	21,432	20,953	Mar 05 02:22 PM
Foehr David	Senior VP, Finance and PAO	Mar 03 '26	Sale	17.80	4,560	81,168	17,550	Mar 05 02:22 PM
ROBERTSON REBECCA B	Director	Mar 03 '26	Sale	17.80	827	14,721	18,749	Mar 05 02:20 PM
Chao Xingjuan	President and CEO	Mar 03 '26	Option Exercise	4.70	25,000	117,500	734,718	Mar 05 02:18 PM
Chao Xingjuan	President and CEO	Mar 03 '26	Sale	17.45	39,000	680,564	711,164	Mar 05 02:18 PM
Woo Raymond	Chief Technology Officer	Mar 02 '26	Option Exercise	4.37	11,112	48,605	173,527	Mar 04 01:28 PM
Woo Raymond	Chief Technology Officer	Mar 02 '26	Sale	18.25	8,087	147,602	166,912	Mar 04 01:28 PM
Chao Xingjuan	Officer	Mar 03 '26	Proposed Sale	17.80	39,000	694,200		Mar 03 01:46 PM
Foehr David	Officer	Mar 03 '26	Proposed Sale	17.80	4,560	81,168		Mar 03 12:17 PM
ROBERTSON REBECCA B	Director	Mar 03 '26	Proposed Sale	17.80	827	14,721		Mar 03 11:37 AM
Woo Raymond	Officer	Mar 02 '26	Proposed Sale	18.14	11,112	201,572		Mar 02 11:56 AM
Foehr David	Senior VP, Finance and PAO	Feb 24 '26	Sale	19.98	781	15,604	17,550	Feb 25 04:46 PM
Foehr David	Senior VP, Finance and PAO	Feb 23 '26	Sale	19.79	569	11,261	18,331	Feb 25 04:46 PM
Manni Joseph S.	Chief Revenue Officer	Feb 23 '26	Sale	19.79	768	15,199	26,933	Feb 25 04:46 PM
Woo Raymond	Chief Technology Officer	Feb 23 '26	Sale	19.79	705	13,952	166,912	Feb 25 04:45 PM
Blumberg Scott	Chief Financial Officer	Feb 23 '26	Sale	19.79	808	15,990	118,334	Feb 25 04:45 PM
Chao Xingjuan	President and CEO	Feb 23 '26	Sale	19.79	2,084	41,242	725,164	Feb 25 04:44 PM
Foehr David	Officer	Feb 24 '26	Proposed Sale	19.98	781	15,604		Feb 24 11:35 AM
Woo Raymond	Officer	Feb 23 '26	Proposed Sale	19.79	705	13,955		Feb 23 04:46 PM
Chao Xingjuan	Officer	Feb 23 '26	Proposed Sale	19.79	2,084	41,252		Feb 23 04:45 PM
Manni Joseph S.	Officer	Feb 23 '26	Proposed Sale	19.79	768	15,202		Feb 23 04:36 PM
Blumberg Scott	Officer	Feb 23 '26	Proposed Sale	19.79	808	15,994		Feb 23 04:34 PM
Foehr David	Officer	Feb 23 '26	Proposed Sale	19.79	569	11,263		Feb 23 04:26 PM
Parvizi Josef	Director	Feb 19 '26	Sale	20.27	16,714	338,793	722,652	Feb 23 12:07 PM
Parvizi Josef	Director	Feb 18 '26	Sale	20.00	6,986	139,720	739,366	Feb 19 04:17 PM
Parvizi Josef	Director	Feb 17 '26	Sale	20.00	1,300	26,000	746,352	Feb 19 04:17 PM
Parvizi Josef	Director	Feb 19 '26	Proposed Sale	20.27	16,714	338,754		Feb 19 04:08 PM
Parvizi Josef	Director	Feb 18 '26	Proposed Sale	20.01	6,986	139,770		Feb 18 04:20 PM
Parvizi Josef	Director	Feb 17 '26	Proposed Sale	20.00	1,300	26,000		Feb 17 04:37 PM
Chao Xingjuan	President and CEO	Feb 04 '26	Option Exercise	4.70	25,000	117,500	750,802	Feb 06 03:51 PM
Chao Xingjuan	President and CEO	Feb 04 '26	Sale	20.16	39,000	786,240	727,248	Feb 06 03:51 PM
Foehr David	Senior VP, Finance and PAO	Feb 03 '26	Option Exercise	4.70	5,556	26,113	22,303	Feb 05 12:54 PM
Foehr David	Senior VP, Finance and PAO	Feb 03 '26	Sale	20.00	5,556	111,120	18,900	Feb 05 12:54 PM
Woo Raymond	Chief Technology Officer	Feb 02 '26	Option Exercise	4.37	11,112	48,605	174,232	Feb 04 04:01 PM
Woo Raymond	Chief Technology Officer	Feb 02 '26	Sale	20.55	11,112	228,375	167,617	Feb 04 04:01 PM
Chao Xingjuan	Officer	Feb 04 '26	Proposed Sale	20.51	39,000	799,890		Feb 04 02:38 PM
Foehr David	Officer	Feb 03 '26	Proposed Sale	20.00	5,556	111,120		Feb 03 10:35 AM
Woo Raymond	Officer	Feb 02 '26	Proposed Sale	20.80	11,112	231,130		Feb 02 03:24 PM
Parvizi Josef	Director	Jan 15 '26	Sale	22.94	25,000	573,500	747,652	Jan 20 04:52 PM
Parvizi Josef	Director	Jan 15 '26	Proposed Sale	22.94	25,000	573,453		Jan 15 04:24 PM
Foehr David	Senior VP, Finance and PAO	Jan 05 '26	Option Exercise	4.70	5,556	26,113	22,303	Jan 07 07:12 PM
Foehr David	Senior VP, Finance and PAO	Jan 05 '26	Sale	22.60	5,556	125,566	18,900	Jan 07 07:12 PM
Chao Xingjuan	President and CEO	Jan 05 '26	Option Exercise	4.70	25,000	117,500	764,802	Jan 07 06:09 PM
Chao Xingjuan	President and CEO	Jan 05 '26	Sale	21.27	79,000	1,680,048	741,248	Jan 07 06:09 PM
Woo Raymond	Chief Technology Officer	Jan 02 '26	Option Exercise	4.37	11,112	48,605	173,932	Jan 06 05:16 PM
Woo Raymond	Chief Technology Officer	Jan 02 '26	Sale	21.18	11,112	235,382	167,317	Jan 06 05:16 PM
ROBERTSON REBECCA B	Director	Jan 02 '26	Option Exercise	2.24	2,500	5,600	22,076	Jan 06 05:16 PM
ROBERTSON REBECCA B	Director	Jan 02 '26	Sale	21.89	2,500	54,725	19,576	Jan 06 05:16 PM
Chao Xingjuan	Officer	Jan 05 '26	Proposed Sale	21.27	79,000	1,680,125		Jan 05 04:46 PM
Foehr David	Officer	Jan 05 '26	Proposed Sale	22.60	5,556	125,566		Jan 05 11:02 AM
ROBERTSON REBECCA B	Director	Jan 02 '26	Proposed Sale	21.89	2,500	54,725		Jan 02 11:21 AM
Woo Raymond	Officer	Jan 02 '26	Proposed Sale	21.89	11,112	243,242		Jan 02 10:52 AM
Blumberg Scott	Chief Financial Officer	Dec 22 '25	Option Exercise	4.23	36,000	152,105	138,561	Dec 29 01:40 PM
Blumberg Scott	Chief Financial Officer	Dec 22 '25	Sale	21.00	36,000	756,000	118,842	Dec 29 01:40 PM
Blumberg Scott	Officer	Dec 22 '25	Proposed Sale	21.00	36,000	756,000		Dec 22 10:01 AM
Parvizi Josef	Director	Dec 15 '25	Sale	21.49	25,000	537,250	772,652	Dec 17 08:07 PM
Parvizi Josef	Director	Dec 15 '25	Proposed Sale	21.55	25,000	538,650		Dec 15 04:34 PM
BURKE WILLIAM W	Director	Dec 09 '25	Option Exercise	3.97	32,728	130,085	40,391	Dec 11 04:48 PM
BURKE WILLIAM W	Director	Dec 09 '25	Sale	22.02	32,728	720,671	17,391	Dec 11 04:48 PM
Parvizi Josef	Director	Dec 08 '25	Sale	20.26	25,000	506,500	797,652	Dec 10 08:00 PM
ROBERTSON REBECCA B	Director	Dec 08 '25	Option Exercise	2.24	5,000	11,200	13,388	Dec 10 01:02 PM
ROBERTSON REBECCA B	Director	Dec 08 '25	Sale	20.00	5,000	100,000	8,388	Dec 10 01:02 PM
BURKE WILLIAM W	Director	Dec 09 '25	Proposed Sale	22.02	32,728	720,688		Dec 09 04:05 PM
Parvizi Josef	Director	Dec 08 '25	Proposed Sale	20.26	25,000	506,467		Dec 08 04:28 PM
Chao Xingjuan	President and CEO	Dec 04 '25	Option Exercise	2.24	25,000	56,000	823,135	Dec 08 01:01 PM
Chao Xingjuan	President and CEO	Dec 04 '25	Sale	18.82	25,000	470,500	798,135	Dec 08 01:01 PM
ROBERTSON REBECCA B	Director	Dec 08 '25	Proposed Sale	20.00	5,000	100,000		Dec 08 12:27 PM
Foehr David	Senior VP, Finance and PAO	Dec 03 '25	Option Exercise	4.70	4,399	20,675	21,630	Dec 05 05:35 PM
Foehr David	Senior VP, Finance and PAO	Dec 03 '25	Sale	16.83	5,265	88,610	19,384	Dec 05 05:35 PM
Chao Xingjuan	Officer	Dec 04 '25	Proposed Sale	18.82	25,000	470,534		Dec 04 04:44 PM
ROBERTSON REBECCA B	Director	Dec 02 '25	Sale	16.67	827	13,786	8,388	Dec 04 02:16 PM
Woo Raymond	Chief Technology Officer	Dec 01 '25	Option Exercise	4.37	11,112	48,605	178,816	Dec 03 01:34 PM
Woo Raymond	Chief Technology Officer	Dec 01 '25	Sale	12.28	11,112	136,455	167,704	Dec 03 01:34 PM
Chao Xingjuan	President and CEO	Dec 01 '25	Option Exercise	3.65	25,000	91,250	823,135	Dec 03 01:33 PM
Chao Xingjuan	President and CEO	Dec 01 '25	Sale	16.59	25,000	414,750	798,135	Dec 03 01:33 PM
Foehr David	Officer	Dec 03 '25	Proposed Sale	16.83	5,265	88,610		Dec 03 10:06 AM
ROBERTSON REBECCA B	Director	Dec 02 '25	Proposed Sale	16.67	827	13,786		Dec 02 09:50 AM
Chao Xingjuan	Officer	Dec 01 '25	Proposed Sale	16.87	25,000	421,750		Dec 01 12:20 PM
Woo Raymond	Officer	Dec 01 '25	Proposed Sale	16.87	11,112	187,459		Dec 01 10:17 AM
Chao Xingjuan	President and CEO	Nov 21 '25	Option Exercise	2.94	50,000	147,250	848,135	Nov 25 06:39 PM
Chao Xingjuan	President and CEO	Nov 21 '25	Sale	15.13	50,000	756,500	798,135	Nov 25 06:39 PM
Chao Xingjuan	Officer	Nov 21 '25	Proposed Sale	15.13	50,000	756,539		Nov 21 04:52 PM
Woo Raymond	Chief Technology Officer	Nov 11 '25	Option Exercise	4.37	11,112	48,605	178,816	Nov 13 01:50 PM
Woo Raymond	Chief Technology Officer	Nov 11 '25	Sale	12.28	11,112	136,455	167,704	Nov 13 01:50 PM
Woo Raymond	Officer	Nov 11 '25	Proposed Sale	12.28	11,112	136,497		Nov 12 07:12 AM
Woo Raymond	Chief Technology Officer	Oct 03 '25	Option Exercise	4.37	11,112	48,605	178,816	Oct 07 06:29 PM
Woo Raymond	Chief Technology Officer	Oct 03 '25	Sale	12.54	11,112	139,344	167,704	Oct 07 06:29 PM
Woo Raymond	Officer	Oct 03 '25	Proposed Sale	12.54	11,112	139,315		Oct 03 04:40 PM
Woo Raymond	Chief Technology Officer	Sep 04 '25	Option Exercise	4.37	11,112	48,605	178,816	Sep 08 01:28 PM
Woo Raymond	Chief Technology Officer	Sep 04 '25	Sale	12.11	11,112	134,566	167,704	Sep 08 01:28 PM
ROBERTSON REBECCA B	Director	Sep 03 '25	Sale	11.36	827	9,395	9,215	Sep 05 02:33 PM
Woo Raymond	Officer	Sep 04 '25	Proposed Sale	12.11	11,112	134,610		Sep 04 04:13 PM
Woo Raymond	Chief Technology Officer	Sep 02 '25	Option Exercise	2.24	20,000	44,800	167,704	Sep 04 12:58 PM
ROBERTSON REBECCA B	Director	Sep 03 '25	Proposed Sale	11.36	827	9,395		Sep 03 10:34 AM
Foehr David	Senior VP, Finance and PAO	Aug 27 '25	Sale	11.71	866	10,141	20,250	Aug 29 12:06 PM
Foehr David	Officer	Aug 27 '25	Proposed Sale	11.71	866	10,143		Aug 27 04:50 PM
Taylor Joseph Michael	Director	Aug 19 '25	Sale	11.76	7,032	82,696	59,235	Aug 21 02:47 PM
Taylor Joseph Michael	Director	Aug 19 '25	Proposed Sale	11.76	7,032	82,690		Aug 19 05:12 PM
Chao Xingjuan	President and CEO	Jul 07 '25	Option Exercise	2.24	25,000	56,000	801,222	Jul 09 02:49 PM
Chao Xingjuan	President and CEO	Jul 07 '25	Sale	17.70	25,000	442,500	776,022	Jul 09 02:49 PM

Open in Screener

CWK

Cushman & Wakefield Ltd

Mar 12 • 03:08PM ET

11.78

-0.29 -2.41 %

Real Estate • Real Estate Services • Bermuda • NYSE

CWK Cushman & Wakefield Ltd daily Stock Chart

Peers: CBRE JLL HFFG MMI BVN FR STWD KIM REG SLG

| Held by: VNQ IJR VTI VB VBR IWM VXF SPSM IJS FESM

Index	RUT	P/E	31.34	EPS (ttm)	0.38	Insider Own	0.50%	Shs Outstand	231.70M	Perf Week	-11.10%
Market Cap	2.73B	Forward P/E	6.97	EPS next Y	1.69	Insider Trans	-0.86%	Shs Float	230.66M	Perf Month	-27.33%
Enterprise Value	4.94B	PEG	0.09	EPS next Q	0.13	Inst Own	91.83%	Short Float	3.87%	Perf Quarter	-21.58%
Income	88.20M	P/S	0.27	EPS this Y	316.60%	Inst Trans	-3.71%	Short Ratio	4.18	Perf Half Y	-26.29%
Sales	10.29B	P/B	1.40	EPS next Y	17.31%	ROA	1.16%	Short Interest	8.92M	Perf YTD	-27.25%
Book/sh	8.44	P/C	3.48	EPS next 5Y	78.60%	ROE	4.75%	52W High	17.40 -32.30%	Perf Year	4.80%
Cash/sh	3.38	P/FCF	9.32	EPS past 3/5Y	-24.16% -	ROIC	1.83%	52W Low	7.64 54.18%	Perf 3Y	1.72%
Dividend Est.	-	EV/EBITDA	8.77	Sales past 3/5Y	0.60% 5.58%	Gross Margin	17.26%	Volatility	6.66% 7.41%	Perf 5Y	-32.34%
Dividend TTM	-	EV/Sales	0.48	EPS Y/Y TTM	-33.30%	Oper. Margin	4.46%	ATR (14)	0.79	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.07	Sales Y/Y TTM	8.91%	Profit Margin	0.86%	RSI (14)	31.16	Recom	1.92
Dividend Gr. 3/5Y	- -	Current Ratio	1.10	EPS Q/Q	-120.10%	SMA20	-9.51%	Beta	1.51	Target Price	18.45
Payout	0.00%	Debt/Eq	1.53	Sales Q/Q	10.81%	SMA50	-21.43%	Rel Volume	0.32	Prev Close	12.07
Employees	52000	LT Debt/Eq	1.47	Earnings	Feb 19 BMO	SMA200	-18.34%	Avg Volume	2.13M	Price	11.78
IPO	Aug 02, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-123.76% 1.38%	Trades		Volume	600,301	Change	-2.41%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-09-26	Upgrade	Wolfe Research	Peer Perform → Outperform	$19
Dec-02-25	Initiated	Barclays	Equal Weight	$18
Nov-21-25	Upgrade	Citigroup	Neutral → Buy	$18
Aug-08-25	Upgrade	Goldman	Sell → Buy	$17.50
Jul-21-25	Initiated	Citizens JMP	Mkt Outperform	$15
Jan-02-25	Downgrade	Jefferies	Buy → Hold	$18 → $14
Dec-06-24	Initiated	Goldman	Sell	$15
Apr-10-24	Initiated	Jefferies	Buy	$13
Apr-09-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-03-24	Downgrade	Raymond James	Strong Buy → Outperform	$13
Dec-08-23	Upgrade	Wolfe Research	Peer Perform → Outperform	$12
Apr-17-23	Downgrade	UBS	Buy → Neutral	$19 → $10
Apr-10-23	Downgrade	Goldman	Buy → Neutral	$15.50 → $11
Feb-01-23	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-05-22	Initiated	Goldman	Buy	$25
Nov-22-21	Upgrade	Raymond James	Outperform → Strong Buy	$31
Jun-15-21	Initiated	Wolfe Research	Outperform	$27
May-17-21	Downgrade	BofA Securities	Neutral → Underperform	$16.50
Jan-25-21	Initiated	Goldman	Neutral	$15.50
Sep-17-20	Initiated	Raymond James	Outperform	$18

Show Previous Ratings

Mar-11-26 10:00AM	Cushman & Wakefield Research Shows Large Warehouse Deals Roar Back as Big-Box Leasing Rebounds Across U.S. (Business Wire)
Mar-09-26 02:14PM	Cushman & Wakefield Arranges $72M Acquisition Financing for Seven-Asset Industrial Portfolio in Maryland (Business Wire)
Mar-06-26 02:15PM	Cushman & Wakefield Named No. 2 Top Real Estate Brand (Business Wire)
Mar-05-26 04:25PM	Your 401(k) could shrink due to climate risks. A lawsuit argues that your employer has a duty to protect it (FastCompany)
07:39AM	Real estate firm hit with class-action lawsuit over climate risk in retirement plan (ESG Dive)
07:00AM	Loading…
Mar-04-26 07:00AM	How commercial property management firms are using AI and hope to use it tomorrow (Facilities Dive)
Mar-03-26 10:03AM	Cushman & Wakefield Recruits NAI Southcoast and JSA Teams in Florida (Business Wire)
Mar-02-26 11:03PM	Cushman & Wakefield (CWK): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-01-26 11:36PM	3 Reasons CWK is Risky and 1 Stock to Buy Instead (StockStory)
Feb-26-26 09:15AM	International Markets and Cushman & Wakefield (CWK): A Deep Dive for Investors (Zacks)
12:34AM	The Top 5 Analyst Questions From Cushman & Wakefield's Q4 Earnings Call (StockStory)
Feb-25-26 12:33PM	5 industries that have gotten rocked by the AI 'scare trade' defining markets this year (Yahoo Finance)
Feb-23-26 10:12AM	Cushman & Wakefield Named to IAOP Global 100 List for 15th Consecutive Year (Business Wire)
05:30AM	AI Anxiety Has Found Its Way to Real-Estate Brokers (The Wall Street Journal)
Feb-21-26 08:43AM	Cushman & Wakefield (CWK) Delivers Record Revenue as Commercial Real Estate Demand Holds Firm (Insider Monkey)
11:00AM	Loading…
Feb-20-26 11:00AM	Cushman & Wakefield Q4 Earnings Call Highlights (MarketBeat)
09:00AM	Cushman & Wakefield Launches Commercial Real Estates First Model Designed to Quantify AI Momentum Across the Built Environment (Business Wire)
06:04AM	Services help drive Cushman & Wakefield Q4 revenue up by 11% (Facilities Dive)
12:34AM	CWK Q4 Deep Dive: Capital Markets Growth, AI Adoption, and Operating Leverage Priorities (StockStory)
Feb-19-26 02:15PM	Analyst Report: Cushman & Wakefield Limited (Morningstar Research)
12:32PM	Cushman & Wakefield plc Q4 2025 Earnings Call Summary (Moby)
11:00AM	Cushman & Wakefield (CWK) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
08:10AM	Cushman & Wakefield (CWK) Q4 Earnings and Revenues Surpass Estimates (Zacks)
07:23AM	Cushman & Wakefield's (NYSE:CWK) Q4 CY2025 Sales Beat Estimates (StockStory)
07:20AM	Cushman & Wakefield: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Cushman & Wakefield Reports Financial Results for the Fourth Quarter and Full Year 2025 (Business Wire)
06:10AM	Cushman & Wakefield (CWK) Rebounds 10% on Q4, FY Earnings Blowout (Insider Monkey)
Feb-17-26 10:01PM	Cushman & Wakefield (CWK) Q4 Earnings Report Preview: What To Look For (StockStory) +9.98%
09:15AM	Unlocking Q4 Potential of Cushman & Wakefield (CWK): Exploring Wall Street Estimates for Key Metrics (Zacks)
Feb-15-26 11:38PM	3 Cash-Producing Stocks That Concern Us (StockStory)
11:32AM	Loading…
11:32AM	AI Disruption Fears Slam Real Estate Brokers (Benzinga)
Feb-13-26 04:21PM	Wolfe Research Upgrades Cushman & Wakefield Limited (CWK) to Outperform and Sets a $19 Price Target (Insider Monkey)
10:44AM	From software to real estate, U.S. sectors under the grip of AI scare trade (Reuters)
10:39AM	Bryan Doyle Joins Cushman & Wakefield as Chief Operating Officer, Americas Capital Markets (Business Wire)
Feb-12-26 04:57PM	AI Disruption Fears Slam Real Estate Brokers (Benzinga) -11.52%
04:35PM	AI Jitters Spread to Commercial Real Estate (The Wall Street Journal)
04:26PM	Real Estate Stocks Sink as Worries About AI Risks Spread (Bloomberg)
12:40PM	Property sector hit as investors bet AI can replace estate agents (The Telegraph)
12:13PM	CBRE Group Q4 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks)
11:51AM	Gabrielle Harvey and Brendan Callahan Join Cushman & Wakefield As Executive Vice Chairs in New England (Business Wire)
11:04AM	Renaissance Loads Up on Netflix, Lam Research, ServiceNow - Smart Money Signals Shift (Benzinga)
10:00AM	Cushman & Wakefield (CWK) Earnings Expected to Grow: Should You Buy? (Zacks)
09:00AM	AI Disruption Hit Multiple Sector ETFs: Is the Fear Overblown? (Zacks)
06:24AM	Stocks Rise Before the Open on U.S. Economic Optimism, Earnings and Jobless Claims Data in Focus (Barchart)
Feb-11-26 06:20PM	Analyst Report: Cushman & Wakefield Limited (Morningstar Research) -13.82%
04:28PM	Cushman & Wakefield leads 14% real estate stock slide on AI fears (Investing.com)
04:26PM	Real Estate Services Stocks Sink in Latest AI Scare Trade (Bloomberg)
10:30AM	Federal Realty to Report Q4 Earnings: What to Expect From the Stock? (Zacks)
Feb-10-26 03:00PM	Cushman & Wakefield Hires Kevin Donner as Vice Chair in Los Angeles (Business Wire)
10:40AM	What's in the Cards for Kimco Realty Stock in Q4 Earnings? (Zacks)
Feb-08-26 10:00AM	Here Is Why Hedge Funds Favor Cushman & Wakefield (CWK) (Insider Monkey)
Feb-05-26 03:08PM	Cushman & Wakefield Hires Damla Gerhart as Executive Regional Director, Midwest Region (Business Wire)
Feb-04-26 10:21AM	Regency Centers to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-02-26 10:00AM	Cushman & Wakefield Announces New Leadership for National Industrial Advisory Group (Business Wire)
Jan-30-26 01:01PM	Gregg Metcalf Joins Cushman & Wakefield as Executive Director (Business Wire)
Jan-29-26 11:02PM	Cushman & Wakefield (CWK): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
10:35AM	What to Expect From Simon Property Stock This Earnings Season? (Zacks)
Jan-28-26 02:51AM	The Zacks Analyst Blog Cushman & Wakefield's, Simon Property, Regency Centers, Kimco and Federal Realty Investment (Zacks)
Jan-22-26 11:55AM	Are Industrial REITs Poised to Grow Amid Recovery in Demand? (Zacks)
09:00AM	Cushman & Wakefield Hires Joey Verrant as Chief Operating Officer of Asset Services Multifamily (Business Wire)
Jan-21-26 09:00AM	Cushman & Wakefield to Release Fourth Quarter and Full Year 2025 Earnings on February 19 (Business Wire)
Jan-15-26 04:10PM	Cushman & Wakefield Expands Occupier Advisory Capabilities with Top Industrial Brokers Joe Howell and Brett Spitzer (Business Wire)
Jan-14-26 10:35PM	Q3 Earnings Outperformers: Cushman & Wakefield (NYSE:CWK) And The Rest Of The Real Estate Services Stocks (StockStory)
09:15AM	Cushman & Wakefield price target raised to $19 from $18 at Barclays (TipRanks)
Jan-05-26 03:00PM	Cushman & Wakefield Hires Andy Jansen as President of Project & Development Services (Business Wire) +5.62%
Dec-30-25 07:40AM	He retired at 34 with $3 million, then had to go back to work after buying a house. How to avoid his mistake (Moneywise)
Dec-10-25 04:30AM	Hong Kong home prices to rise in 2026 on the back of mainland Chinese buyers, rate cut (South China Morning Post)
Dec-04-25 02:30PM	Cushman & Wakefield Forecasts U.S. CRE Market Shift From Resilience to Optimism in 2026 (Business Wire)
Dec-03-25 10:00AM	Cushman & Wakefield Secures Global Contract Extension with BHP (Business Wire)
Nov-28-25 08:02AM	Cushman & Wakefield Completes Redomiciliation to Bermuda (Business Wire)
Nov-24-25 11:41AM	Cushman & Wakefield Expands Retail Expertise with Appointments of Jessica Gangoso and Kristen Pash (Business Wire)
Nov-21-25 05:16PM	Why Is Cushman & Wakefield (CWK) Stock Rocketing Higher Today (StockStory) +8.62%
09:10AM	Here Are Fridays Top Wall Street Analysts Research Calls: Advanced Micro Devices, Block, Broadcom, Exact Sciences, Hologic, Palo Alto Networks and More (24/7 Wall St.)
Nov-18-25 05:31PM	Analyst Report: Cushman & Wakefield plc (Morningstar Research)
Nov-17-25 04:55AM	Investors return to German hotels, but risks remain (Hotel Management Network)
Nov-11-25 11:00AM	Cushman & Wakefield Earns 2026 Military Friendly Employer Designation, Expands Veteran Initiatives Nationwide (Business Wire)
Nov-10-25 11:59PM	REMAX Canada Strengthens Commercial Division with Appointment of Damon Conrad as Vice President (Albuquerque Journal, N.M.)
Nov-03-25 04:37PM	Are Options Traders Betting on a Big Move in Cushman & Wakefield Stock? (Zacks)
Oct-31-25 08:50AM	Despite Fast-paced Momentum, Cushman & Wakefield (CWK) Is Still a Bargain Stock (Zacks)
Oct-30-25 04:37PM	Cushman & Wakefield PLC (CWK) Q3 2025 Earnings Call Highlights: Record Leasing Revenue and ... (GuruFocus.com)
02:53PM	Analyst Report: Cushman & Wakefield plc (Morningstar Research)
09:30AM	Compared to Estimates, Cushman & Wakefield (CWK) Q3 Earnings: A Look at Key Metrics (Zacks)
08:42AM	Cushman & Wakefield (NYSE:CWK) Surprises With Strong Q3 (StockStory)
08:15AM	Cushman & Wakefield (CWK) Q3 Earnings and Revenues Top Estimates (Zacks)
07:44AM	Cushman & Wakefield benefits from flight to quality, service improvements (Facilities Dive)
07:17AM	Cushman & Wakefield: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Cushman & Wakefield Reports Financial Results for the Third Quarter 2025 (Business Wire)
Oct-29-25 01:47PM	Here's What to Expect From Simon Property This Earnings Season (Zacks)
09:36AM	Cushman & Wakefield PLC (CWK) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-28-25 11:06PM	Cushman & Wakefield (CWK) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
12:23PM	Federal Realty to Report Q3 Earnings: What to Expect From the Stock? (Zacks)
10:30AM	Cushman & Wakefield Launches New Quantitative Insights Group Led by Rebecca Rockey (Business Wire)
10:00AM	Colliers International (CIGI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-27-25 05:00PM	Cushman & Wakefield Advises Urban Industrial on 470 Million Refinancing (Business Wire)
Oct-24-25 01:00PM	Cushman & Wakefield Adds Walid Cheaib to Canadian Capital Markets Team as Vice Chair (Business Wire)
12:10PM	Will Cushman & Wakefield (CWK) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Oct-23-25 02:31PM	CBRE Group Q3 Earnings Beat Estimates, 2025 EPS Outlook Raised (Zacks)
08:52AM	Cushman & Wakefield to Host 2025 Investor Day on December 4 (Business Wire)
Oct-22-25 01:35PM	Regency Centers to Post Q3 Earnings: What's in Store for the Stock? (Zacks)
Oct-21-25 04:30PM	Cushman & Wakefield Successfully Amends and Extends Revolving Credit Facility (Business Wire)

Cushman & Wakefield Ltd. s a global commercial real estate services firm for property owners. The company is headquartered in Hamilton, Bermuda.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Robinson Nathaniel	See Remarks	Mar 03 '26	Sale	13.50	10,000	135,000	105,704	Mar 04 04:03 PM
Robinson Nathaniel	Officer	Mar 03 '26	Proposed Sale	13.50	10,000	135,000		Mar 03 02:34 PM
Robinson Nathaniel	See Remarks	Feb 27 '26	Option Exercise	0.00	14,005	0	119,661	Mar 02 04:11 PM
MCDONALD ANDREW R.	See Remarks	Feb 27 '26	Option Exercise	0.00	53,921	0	477,805	Mar 02 04:10 PM
MACKAY MICHELLE	Chief Executive Officer	Feb 27 '26	Option Exercise	0.00	101,540	0	471,256	Mar 02 04:04 PM
JOHNSTON NEIL O	See Remarks	Feb 27 '26	Option Exercise	0.00	30,812	0	330,741	Mar 02 04:03 PM
Perkins Noelle J	See Remarks	Feb 27 '26	Option Exercise	0.00	15,406	0	78,471	Mar 02 04:02 PM
Sayed Laurida	See Remarks	Feb 27 '26	Option Exercise	0.00	5,602	0	23,116	Mar 02 04:01 PM
JOHNSTON NEIL O	See Remarks	Feb 25 '26	Option Exercise	0.00	146,337	0	358,070	Feb 27 04:53 PM
MACKAY MICHELLE	Chief Executive Officer	Feb 25 '26	Option Exercise	0.00	202,877	0	481,907	Feb 27 04:52 PM
MCDONALD ANDREW R.	See Remarks	Feb 25 '26	Option Exercise	0.00	186,249	0	518,648	Feb 27 04:51 PM
Robinson Nathaniel	See Remarks	Feb 25 '26	Option Exercise	0.00	53,213	0	118,614	Feb 27 04:50 PM
MCDONALD ANDREW R.	See Remarks	Feb 23 '26	Option Exercise	0.00	34,878	0	350,336	Feb 24 04:13 PM
JOHNSTON NEIL O	See Remarks	Feb 23 '26	Option Exercise	0.00	27,405	0	220,132	Feb 24 04:10 PM
Robinson Nathaniel	See Remarks	Feb 23 '26	Option Exercise	0.00	9,966	0	68,272	Feb 24 04:10 PM
MACKAY MICHELLE	Chief Executive Officer	Feb 23 '26	Option Exercise	0.00	37,992	0	300,033	Feb 24 04:09 PM
Sayed Laurida	See Remarks	Feb 23 '26	Option Exercise	0.00	2,492	0	18,377	Feb 24 04:08 PM
Sayed Laurida	See Remarks	Feb 22 '26	Option Exercise	0.00	6,661	0	18,191	Feb 24 04:08 PM
Perkins Noelle J	See Remarks	Feb 22 '26	Option Exercise	0.00	14,985	0	67,820	Feb 24 04:06 PM
Sun Angela	Director	Sep 05 '25	Sale	16.02	6,800	108,936	46,498	Sep 09 08:48 AM
Sun Angela	Director	Sep 05 '25	Proposed Sale	16.02	6,800	108,936		Sep 05 10:31 AM
MACKAY MICHELLE	Chief Executive Officer	Jul 01 '25	Option Exercise	0.00	24,959	0	275,844	Jul 02 02:49 PM
MCDONALD ANDREW R.	See Remarks	Jul 01 '25	Option Exercise	0.00	10,697	0	320,890	Jul 02 02:45 PM
Perkins Noelle J	See Remarks	Jul 01 '25	Option Exercise	0.00	30,562	0	62,377	Jul 02 02:41 PM
WHITE W BRETT	Director	May 16 '25	Option Exercise	0.00	24,953	0	1,645,704	May 19 04:05 PM
Sun Angela	Director	May 16 '25	Option Exercise	0.00	15,451	0	53,298	May 19 04:05 PM
Williamson Billie Ida	Director	May 16 '25	Option Exercise	0.00	15,451	0	88,992	May 19 04:05 PM
McPeek Jennifer J	Director	May 16 '25	Option Exercise	0.00	15,451	0	18,503	May 19 04:05 PM
FELMAN MICHELLE	Director	May 16 '25	Option Exercise	0.00	15,451	0	27,844	May 19 04:05 PM
Vennam Rajesh	Director	May 16 '25	Option Exercise	0.00	15,451	0	18,503	May 19 04:05 PM
McLean Jodie W.	Director	May 16 '25	Option Exercise	0.00	15,451	0	71,823	May 19 04:05 PM

LFST

LifeStance Health Group Inc

SION

Sionna Therapeutics Inc

LTH

Life Time Group Holdings Inc

CBLL

Ceribell Inc

CWK

Cushman & Wakefield Ltd

Upgrade your FINVIZ experience